Advances in Alzheimer’s disease therapeutics: biochemistry, exploring bioactive compounds and novel approaches

Ayomide Victor Atokia Department of Biochemistry, Kampala International University, Bushenyi, UgandaCorrespondence[email protected]

https://orcid.org/0000-0003-1914-973X View further author information

Patrick Maduabuchi Ajaa Department of Biochemistry, Kampala International University, Bushenyi, Uganda;b Department of Biochemistry, Faculty of Science, Ebonyi State University, Abakaliki, NigeriaView further author information

Erick Nyakundi Ondaria Department of Biochemistry, Kampala International University, Bushenyi, Uganda;c School of Pure and Applied Sciences, Department of Biological Sciences, Kisii University, Kisii, KenyaView further author information

Tijjani Salihu Shinkafia Department of Biochemistry, Kampala International University, Bushenyi, UgandaView further author information

Pages 2091-2127 | Received 01 May 2023, Accepted 27 Jul 2023, Published online: 03 Aug 2023

Cite this article
https://doi.org/10.1080/10942912.2023.2243050
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

References

Iqbal, K.; Grundke-Iqbal, I. Alzheimer’s Disease, a Multifactorial Disorder Seeking Multitherapies. Alzheimer’s & Dementia. 2010, 6(5), 420–424. DOI: 10.1016/j.jalz.2010.04.006.
PubMed Web of Science ®Google Scholar
Singh, A.; Kukreti, R.; Saso, L.; Kukreti, S. Oxidative Stress: A Key Modulator in Neurodegenerative Diseases. Molecules. 2019, 24(8), 1583. DOI: 10.3390/molecules24081583.
PubMed Web of Science ®Google Scholar
Cobley, J. N.; Fiorello, M. L.; Bailey, D. M. 13 Reasons Why the Brain is Susceptible to Oxidative Stress. Redox Biol. 2018, 15, 490–503. DOI: 10.1016/j.redox.2018.01.008.
PubMed Web of Science ®Google Scholar
Oboh, G.; Rocha, J. B. T. Antioxidant and Neuroprotective Properties of Sour Tea (Hibiscus Sabdariffa, Calyx) and Green Tea (Camellia Sinensis) on Some Pro-Oxidant-Induced Lipid Peroxidation in Brain In Vitro. Food Biophys. 2008, 3(4), 382–389. DOI: 10.1007/s11483-008-9092-5.
Web of Science ®Google Scholar
Isik, A. T. Late Onset Alzheimer’s Disease in Older People. Clin. Interventions Aging. 2010, 307–311. DOI: 10.2147/CIA.S11718.
PubMed Web of Science ®Google Scholar
Macdonald, I. R.; Rockwood, K.; Martin, E.; Darvesh, S. Cholinesterase Inhibition in Alzheimer’s Disease: Is Specificity the Answer? J. Alzheimer’s Dis. 2014, 42(2), 379–384. DOI: 10.3233/JAD-140219.
PubMed Web of Science ®Google Scholar
Webber, K. M.; Raina, A. K.; Marlatt, M. W.; Zhu, X.; Prat, M. I.; Morelli, L.; Smith, M. A. The Cell Cycle in Alzheimer Disease: A Unique Target for Neuropharmacology. Mech. Ageing Dev. 2005, 126(10), 1019–1025. DOI: 10.1016/j.mad.2005.03.024.
PubMed Web of Science ®Google Scholar
Michalke, B.; Willkommen, D.; Drobyshev, E.; Solovyev, N. The Importance of Speciation Analysis in Neurodegeneration Research. TrAc Trends Anal. Chem. 2018, 104, 160–170. DOI: 10.1016/j.trac.2017.08.008.
Web of Science ®Google Scholar
Oboh, G.; Agunloye, O. M.; Akinyemi, A. J.; Ademiluyi, A. O.; Adefegha, S. A. Comparative Study on the Inhibitory Effect of Caffeic and Chlorogenic Acids on Key Enzymes Linked to Alzheimer’s Disease and Some Pro-Oxidant Induced Oxidative Stress in rats’ Brain-In Vitro. Neurochem. Res. 2013a, 38(2), 413–419. DOI: 10.1007/s11064-012-0935-6.
PubMed Web of Science ®Google Scholar
Zago, M. P.; Verstraeten, S. V.; Oteiza, P. I. Zinc in the Prevention of Fe2+ initiated Lipid and Protein Oxidation. Biol. Res. 2000, 33, 143–150. DOI: 10.4067/S0716-97602000000200014.
PubMed Web of Science ®Google Scholar
Wimo, A.; Guerchet, M.; Ali, G.-C.; Wu, Y.-T.; Prina, A. M.; Winblad, B.; Jönsson, L.; Liu, Z.; Prince, M. The Worldwide Costs of Dementia 2015 and Comparisons with 2010. Alzheimer’s & Dementia. 2017, 13, 1–7. DOI: 10.1016/j.jalz.2016.07.150.
PubMed Web of Science ®Google Scholar
Herrmann, L. K.; Welter, E.; Leverenz, J.; Lerner, A. J.; Udelson, N.; Kanetsky, C.; Sajatovic, M. A Systematic Review of Dementia-Related Stigma Research: Can We Move the Stigma Dial? Am. J. Geriatric Psychiatry. 2018, 26(3), 316–331. DOI: 10.1016/j.jagp.2017.09.006.
PubMed Web of Science ®Google Scholar
Podcasy, J. L.; Epperson, C. N. Considering Sex and Gender in Alzheimer Disease and Other Dementias. Dialogues Clin. Neurosci. 2022, 18, 2016(4), 437–446.
Google Scholar
Mahdi, O.; Baharuldin, M. T. H.; Nor, N. H. M.; Chiroma, S. M.; Jagadeesan, S.; Moklas, M. A. M. Chemicals Used for the Induction of Alzheimer’s Disease-Like Cognitive Dysfunctions in Rodents. Biomed. Res. Ther. 2019, 6, 3460–3484. DOI: 10.15419/bmrat.v6i11.575.
Web of Science ®Google Scholar
Nakanishi, M.; Igarashi, A.; Ueda, K.; Brnabic, A. J. M.; Treuer, T.; Sato, M.; Kahle-Wrobleski, K.; Meguro, K.; Yamada, M.; Mimura, M. Costs and Resource Use Associated with Community-Dwelling Patients with Alzheimer’s Disease in Japan: Baseline Results from the Prospective Observational GERAS-J Study. J. Alzheimer’s Dis. 2020, 74, 127–138. DOI: 10.3233/JAD-190811.
PubMed Web of Science ®Google Scholar
Ferreira, M. E. S.; de Vasconcelos, A. S.; da Costa Vilhena, T.; da Silva, T. L.; da Silva Barbosa, A.; Gomes, A. R. Q.; Dolabela, M. F.; Percário, S. Oxidative Stress in Alzheimer’s Disease: Should We Keep Trying Antioxidant Therapies? Cell Mol. Neurobiol. 2015, 35, 595–614. DOI: 10.1007/s10571-015-0157-y.
PubMed Web of Science ®Google Scholar
Liu, P.-P.; Xie, Y.; Meng, X.-Y.; Kang, J.-S. History and Progress of Hypotheses and Clinical Trials for Alzheimer’s Disease. Signal Transduct. Target. Ther. 2019, 4, 29. DOI: 10.1038/s41392-019-0063-8.
PubMed Web of Science ®Google Scholar
Peera, K.; Yellamma, K. Sericin as a Chlinergic Modulator in Alzaeimer’s Disease Induced Rat. Int. J. Pharm. Pharm. Sci. 2015, 7, 108–112.
Google Scholar
Wu, T.; Dejanovic, B.; Gandham, V. D.; Gogineni, A.; Edmonds, R.; Schauer, S.; Srinivasan, K.; Huntley, M. A.; Wang, Y.; Wang, T.-M. Complement C3 is Activated in Human AD Brain and is Required for Neurodegeneration in Mouse Models of Amyloidosis and Tauopathy. Cell. Rep. 2019, 28, 2111–2123. DOI: 10.1016/j.celrep.2019.07.060.
PubMed Web of Science ®Google Scholar
Butterfield, D. A.; Halliwell, B. Oxidative Stress, Dysfunctional Glucose Metabolism and Alzheimer Disease. Nat. Rev. Neurosci. 2019, 20(3), 148–160. DOI: 10.1038/s41583-019-0132-6.
PubMed Web of Science ®Google Scholar
Markesbery, W. R.; Lovell, M. A. Damage to Lipids, Proteins, DNA, and RNA in Mild Cognitive Impairment. Arch. Neurol. 2007, 64(7), 954–956. DOI: 10.1001/archneur.64.7.954.
PubMedGoogle Scholar
Waldemar, G.; Dubois, B.; Emre, M.; Georges, J.; McKeith, I. G.; Rossor, M.; Scheltens, P.; Tariska, P.; Winblad, B. Recommendations for the Diagnosis and Management of Alzheimer’s Disease and Other Disorders Associated with Dementia: EFNS Guideline. Eur. J. Neurol. 2007, 14(1), e1–e26. DOI: 10.1111/j.1468-1331.2006.01605.x.
PubMed Web of Science ®Google Scholar
Ritchie, C.; Smailagic, N.; Noel‐Storr, A. H.; Takwoingi, Y.; Flicker, L.; Mason, S. E.; McShane, R. Plasma and Cerebrospinal Fluid Amyloid Beta for the Diagnosis of Alzheimer’s Disease Dementia and Other Dementias in People with Mild Cognitive Impairment (MCI). Cochrane Database Syst. Rev. 2014, 6. DOI: 10.1002/14651858.CD008782.pub4.
Web of Science ®Google Scholar
Bäckman, L.; Jones, S.; Berger, A.; Laukka, E. J.; Small, B. J. Multiple Cognitive Deficits During the Transition to Alzheimer’s Disease. J. Intern. Med. 2004, 256(3), 195–204. DOI: 10.1111/j.1365-2796.2004.01386.x.
PubMed Web of Science ®Google Scholar
Stella, F.; Radanovic, M.; Balthazar, M. L. F.; Canineu, P. R.; de Souza, L. C.; Forlenza, O. V. Neuropsychiatric Symptoms in the Prodromal Stages of Dementia. Curr. Opin. Psychiatry. 2014, 27, 230–235. DOI: 10.1097/YCO.0000000000000050.
PubMed Web of Science ®Google Scholar
Anderson, N. D. State of the Science on Mild Cognitive Impairment (MCI). CNS Spectr. 2019, 24(1), 78–87. DOI: 10.1017/S1092852918001347.
PubMed Web of Science ®Google Scholar
Petersen, S. L.; Wang, L.; Yalcin-Chin, A.; Li, L.; Peyton, M.; Minna, J.; Harran, P.; Wang, X. Autocrine TNFα Signaling Renders Human Cancer Cells Susceptible to Smac-Mimetic-Induced Apoptosis. Cancer Cell. 2007, 12(5), 445–456. DOI: 10.1016/j.ccr.2007.08.029.
PubMed Web of Science ®Google Scholar
Perrotta, G. Alzheimer’s Disease: Definition, Contexts, Neural Correlates, Strategies and Clinical Approaches. J. Aging Stud. Ther. 2019, 1, 15.
Google Scholar
Doolen, A. C.; Radvansky, G. A. A Novel Study: Long-Lasting Event Memory. Memory. 2021, 29(8), 963–982. DOI: 10.1080/09658211.2021.1953079.
PubMed Web of Science ®Google Scholar
Fraser, K. C.; Meltzer, J. A.; Rudzicz, F. Linguistic Features Identify Alzheimer’s Disease in Narrative Speech. J. Alzheimer’s Dis. 2016, 49, 407–422. DOI: 10.3233/JAD-150520.
PubMed Web of Science ®Google Scholar
Svanström, R.; Sundler, A. J. Gradually Losing One’s Foothold–A Fragmented Existence When Living Alone with Dementia. Dementia. 2015, 14(2), 145–163. DOI: 10.1177/1471301213494510.
PubMedGoogle Scholar
Nishio, Y.; Yokoi, K.; Hirayama, K.; Ishioka, T.; Hosokai, Y.; Gang, M.; Uchiyama, M.; Baba, T.; Suzuki, K.; Takeda, A. Defining Visual Illusions in Parkinson’s Disease: Kinetopsia and Object Misidentification Illusions. Parkinsonism Relat. Disord. 2018, 55, 111–116. DOI: 10.1016/j.parkreldis.2018.05.023.
PubMed Web of Science ®Google Scholar
Wimo, A.; Reed, C. C.; Dodel, R.; Belger, M.; Jones, R. W.; Happich, M.; Argimon, J. M.; Bruno, G.; Novick, D.; Vellas, B. The GERAS Study: A Prospective Observational Study of Costs and Resource Use in Community Dwellers with Alzheimer’s Disease in Three European Countries–Study Design and Baseline Findings. J. Alzheimer’s Dis. 2013, 36, 385–399. DOI: 10.3233/JAD-122392.
PubMed Web of Science ®Google Scholar
Tarawneh, R.; Holtzman, D. M. The Clinical Problem of Symptomatic Alzheimer Disease and Mild Cognitive Impairment. Cold Spring Harb. Perspect. Med. 2012, 2(5), a006148. DOI: 10.1101/cshperspect.a006148.
PubMed Web of Science ®Google Scholar
Sayeed Ahmad, S.; Akhtar, S.; Mohammad Sajid Jamal, Q.; A Kamal, M.; Khan, K. A.; Siddiqui, H. Multiple Targets for the Management of Alzheimer’s Disease. CNS Neurol. Disord-Drug Targets (Formerly Current Drug Targets-CNS & Neurol. Disord). 2016, 15, 1279–1289. DOI: 10.2174/1871527315666161003165855.
PubMed Web of Science ®Google Scholar
Goedert, M.; Spillantini, M. G. Propagation of Tau Aggregates. Mol. Brain. 2017, 10(1), 1–9. DOI: 10.1186/s13041-017-0298-7.
PubMedGoogle Scholar
Onatsu, J.; Vanninen, R.; JÄkÄlÄ, P.; Mustonen, P.; Pulkki, K.; Korhonen, M.; Hedman, M.; Höglund, K.; Blennow, K.; Zetterberg, H. Tau, S100B and NSE as Blood Biomarkers in Acute Cerebrovascular Events. Vivo (Brooklyn). 2020, 34, 2577–2586. DOI: 10.21873/invivo.12075.
Web of Science ®Google Scholar
Chornenkyy, Y.; Fardo, D. W.; Nelson, P. T. Tau and TDP-43 Proteinopathies: Kindred Pathologic Cascades and Genetic Pleiotropy. Lab. Invest. 2019, 99(7), 993–1007. DOI: 10.1038/s41374-019-0196-y.
PubMed Web of Science ®Google Scholar
Williams, D. R. Tauopathies: Classification and Clinical Update on Neurodegenerative Diseases Associated with Microtubule‐Associated Protein Tau. Intern. Med. J. 2006, 36(10), 652–660. DOI: 10.1111/j.1445-5994.2006.01153.x.
PubMed Web of Science ®Google Scholar
Hensley, K.; Kursula, P. Collapsin Response Mediator Protein-2 (CRMP2) is a Plausible Etiological Factor and Potential Therapeutic Target in Alzheimer’s Disease: Comparison and Contrast with Microtubule-Associated Protein Tau. J. Alzheimer’s Dis. 2016, 53, 1–14. DOI: 10.3233/JAD-160076.
PubMed Web of Science ®Google Scholar
Dickson, D. W.; Braak, H.; Duda, J. E.; Duyckaerts, C.; Gasser, T.; Halliday, G. M.; Hardy, J.; Leverenz, J. B.; Del Tredici, K.; Wszolek, Z. K. Neuropathological Assessment of Parkinson’s Disease: Refining the Diagnostic Criteria. Lancet. Neurol. 2009, 8, 1150–1157. DOI: 10.1016/S1474-4422(09)70238-8.
PubMed Web of Science ®Google Scholar
Goedert, M. Tau Gene Mutations and Their Effects. Mov. Disord. 2005, 20(S12), S45–S52. DOI: 10.1002/mds.20539.
PubMedGoogle Scholar
Kadas, D.; Papanikolopoulou, K.; Xirou, S.; Consoulas, C.; Skoulakis, E. M. C. Human Tau Isoform-Specific Presynaptic Deficits in a Drosophila Central Nervous System Circuit. Neurobiol. Dis. 2019, 124, 311–321. DOI: 10.1016/j.nbd.2018.12.004.
PubMed Web of Science ®Google Scholar
Sergeant, J. A. Modeling Attention-Deficit/hyperactivity Disorder: A Critical Appraisal of the Cognitive-Energetic Model. Biol. Psychiatry. 2005, 57(11), 1248–1255. DOI: 10.1016/j.biopsych.2004.09.010.
PubMed Web of Science ®Google Scholar
Iqbal, K.; Gong, C.-X.; Liu, F. Microtubule-Associated Protein Tau as a Therapeutic Target in Alzheimer’s Disease. Expert Opin. Ther. Targets. 2014, 18, 307–318. DOI: 10.1517/14728222.2014.870156.
PubMed Web of Science ®Google Scholar
Henderson, M. X.; Sengupta, M.; Trojanowski, J. Q.; Lee, V. M. Y. Alzheimer’s Disease Tau is a Prominent Pathology in LRRK2 Parkinson’s Disease. Acta Neuropathol. Commun. 2019, 7, 1–16. DOI: 10.1186/s40478-019-0836-x.
PubMed Web of Science ®Google Scholar
Šimić, G.; Babić Leko, M.; Wray, S.; Harrington, C.; Delalle, I.; Jovanov-Milošević, N.; Bažadona, D.; Buée, L.; De Silva, R.; Di Giovanni, G. Tau Protein Hyperphosphorylation and Aggregation in Alzheimer’s Disease and Other Tauopathies, and Possible Neuroprotective Strategies. Biomolecules. 2016, 6(1), 6. DOI: 10.3390/biom6010006.
PubMed Web of Science ®Google Scholar
Castellani, R. J.; Perry, G. Tau Biology, Tauopathy, Traumatic Brain Injury, and Diagnostic Challenges. J. Alzheimer’s Dis. 2019, 67, 447–467. DOI: 10.3233/JAD-180721.
PubMed Web of Science ®Google Scholar
Nizynski, B.; Dzwolak, W.; Nieznanski, K. Amyloidogenesis of Tau Protein. Protein Sci. 2017, 26(11), 2126–2150. DOI: 10.1002/pro.3275.
PubMed Web of Science ®Google Scholar
Mokhtar, S. H.; Bakhuraysah, M. M.; Cram, D. S.; Petratos, S. The Beta-Amyloid Protein of Alzheimer’s Disease: Communication Breakdown by Modifying the Neuronal Cytoskeleton. Int. J. Alzheimers Dis. 2013, 2013, 1–15. DOI: 10.1155/2013/910502.
Google Scholar
Luna-Viramontes, N. I.; Campa-Córdoba, B. B.; Ontiveros-Torres, M. Á.; Harrington, C. R.; Villanueva-Fierro, I.; Guadarrama-Ortíz, P.; Garcés-Ramírez, L.; de la Cruz, F.; Hernandes-Alejandro, M.; Martínez-Robles, S. PHF-Core Tau as the Potential Initiating Event for Tau Pathology in Alzheimer’s Disease. Front. Cell. Neurosci. 2020, 14, 247. DOI: 10.3389/fncel.2020.00247.
PubMed Web of Science ®Google Scholar
De Vos, K. J.; Hafezparast, M. Neurobiology of Axonal Transport Defects in Motor Neuron Diseases: Opportunities for Translational Research? Neurobiol. Dis. 2017, 105, 283–299. DOI: 10.1016/j.nbd.2017.02.004.
PubMed Web of Science ®Google Scholar
Ising, C.; Heneka, M. T. Functional and Structural Damage of Neurons by Innate Immune Mechanisms During Neurodegeneration. Cell Death Dis. 2018, 9(2), 120. DOI: 10.1038/s41419-017-0153-x.
PubMedGoogle Scholar
Thornton, C.; Bright, N. J.; Sastre, M.; Muckett, P. J.; Carling, D. AMP-Activated Protein Kinase (AMPK) is a Tau Kinase, Activated in Response to Amyloid β-Peptide Exposure. Biochem. J. 2011, 434(3), 503–512. DOI: 10.1042/BJ20101485.
PubMedGoogle Scholar
Kimura, T.; Ishiguro, K.; Hisanaga, S. Physiological and Pathological Phosphorylation of Tau by Cdk5. Front Mol. Neurosci. 2014, 7, 65. DOI: 10.3389/fnmol.2014.00065.
PubMed Web of Science ®Google Scholar
Forner, S.; Baglietto-Vargas, D.; Martini, A. C.; Trujillo-Estrada, L.; LaFerla, F. M. Synaptic Impairment in Alzheimer’s Disease: A Dysregulated Symphony. Trends Neurosci. 2017, 40, 347–357. DOI: 10.1016/j.tins.2017.04.002.
PubMed Web of Science ®Google Scholar
Maccioni, R. B.; Farías, G.; Morales, I.; Navarrete, L. The Revitalized Tau Hypothesis on Alzheimer’s Disease. Arch. Med. Res. 2010, 41(3), 226–231. DOI: 10.1016/j.arcmed.2010.03.007.
PubMed Web of Science ®Google Scholar
Amadoro, G.; Corsetti, V.; Ciotti, M. T.; Florenzano, F.; Capsoni, S.; Amato, G.; Calissano, P. Endogenous Aβ Causes Cell Death via Early Tau Hyperphosphorylation. Neurobiol. Aging. 2011, 32(6), 969–990. DOI: 10.1016/j.neurobiolaging.2009.06.005.
PubMed Web of Science ®Google Scholar
Roberson, E. D.; Scearce-Levie, K.; Palop, J. J.; Yan, F.; Cheng, I. H.; Wu, T.; Gerstein, H.; Yu, G.-Q.; Mucke, L. Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer’s Disease Mouse Model. Science. 2007, 316, 750–754. DOI: 10.1126/science.1141736.
PubMed Web of Science ®Google Scholar
Bulic, B.; Pickhardt, M.; Mandelkow, E.-M.; Mandelkow, E. Tau Protein and Tau Aggregation Inhibitors. Neuropharmacology. 2010, 59(4–5), 276–289. DOI: 10.1016/j.neuropharm.2010.01.016.
PubMed Web of Science ®Google Scholar
Pîrşcoveanu, D. F. V.; Pirici, I.; Tudorică, V.; Bălşeanu, T.-A.; Albu, V.-C.; Bondari, S.; Bumbea, A. M.; Pîrşcoveanu, M. Tau Protein in Neurodegenerative Diseases-A Review. Rom. J. Morphol. Embryol. 2017, 58, 1141–1150.
PubMed Web of Science ®Google Scholar
Alonso, A. D. C.; Li, B.; Grundke-Iqbal, I.; Iqbal, K. Polymerization of Hyperphosphorylated Tau into Filaments Eliminates Its Inhibitory Activity. Proc. Natl. Acad. Sci. USA. 2006, 103(23), 8864–8869. DOI: 10.1073/pnas.0603214103.
PubMed Web of Science ®Google Scholar
Cowan, C. M.; Bossing, T.; Page, A.; Shepherd, D.; Mudher, A. Soluble Hyper-Phosphorylated Tau Causes Microtubule Breakdown and Functionally Compromises Normal Tau In Vivo. Acta. Neuropathol. 2010, 120(5), 593–604. DOI: 10.1007/s00401-010-0716-8.
PubMed Web of Science ®Google Scholar
Corbo, C. P.; Alonso, A. D. C. Therapeutic Targets in Alzheimer’s Disease and Related Tauopathies. Prog. mol. biol. transl. sci. 2011, 98, 47–83.
PubMed Web of Science ®Google Scholar
Steinhilb, M. L.; Dias‐Santagata, D.; Mulkearns, E. E.; Shulman, J. M.; Biernat, J.; Mandelkow, E.; Feany, M. B. S/P and T/P Phosphorylation is Critical for Tau Neurotoxicity in Drosophila. J. Neurosci. Res. 2007, 85(6), 1271–1278. DOI: 10.1002/jnr.21232.
PubMed Web of Science ®Google Scholar
Blard, O.; Feuillette, S.; Bou, J.; Chaumette, B.; Frébourg, T.; Campion, D.; Lecourtois, M. Cytoskeleton Proteins are Modulators of Mutant Tau-Induced Neurodegeneration in Drosophila. Hum. Mol. Genet. 2007, 16(5), 555–566. DOI: 10.1093/hmg/ddm011.
PubMed Web of Science ®Google Scholar
Bilkei-Gorzo, A. Genetic Mouse Models of Brain Ageing and Alzheimer’s Disease. Pharmacol. Ther. 2014, 142(2), 244–257. DOI: 10.1016/j.pharmthera.2013.12.009.
PubMed Web of Science ®Google Scholar
Takahashi, R. H.; Nagao, T.; Gouras, G. K. Plaque Formation and the Intraneuronal Accumulation of β‐Amyloid in Alzheimer’s Disease. Pathol. Int. 2017, 67, 185–193. DOI: 10.1111/pin.12520.
PubMed Web of Science ®Google Scholar
Soldano, A.; Hassan, B. A. Beyond Pathology: APP, Brain Development and Alzheimer’s Disease. Curr. Opin. Neurobiol. 2014, 27, 61–67. DOI: 10.1016/j.conb.2014.02.003.
PubMed Web of Science ®Google Scholar
Ryu, J.; Yu, H.-N.; Cho, H.; Kim, H.-S.; Baik, T.-K.; Lee, S.-J.; Woo, R.-S. Neuregulin-1 Exerts Protective Effects Against Neurotoxicities Induced by C-Terminal Fragments of APP via ErbB4 Receptor. J. Pharmacol. Sci. 2012, 119(1), 73–81. DOI: 10.1254/jphs.12057FP.
PubMed Web of Science ®Google Scholar
Barthelson, K.; Newman, M.; Lardelli, M. Sorting Out the Role of the Sortilin-Related Receptor 1 in Alzheimer’s Disease. J. Alzheimers Dis. Rep. 2020, 4, 123–140. DOI: 10.3233/ADR-200177.
PubMedGoogle Scholar
Nguyen, T. V.; Galvan, V.; Huang, W.; Banwait, S.; Tang, H.; Zhang, J.; Bredesen, D. E. Signal Transduction in Alzheimer Disease: P21‐Activated Kinase Signaling Requires C‐Terminal Cleavage of APP at Asp664. J. Neurochem. 2008, 104, 1065–1080. DOI: 10.1111/j.1471-4159.2007.05031.x.
PubMed Web of Science ®Google Scholar
Muresan, V.; Varvel, N. H.; Lamb, B. T.; Muresan, Z. The Cleavage Products of Amyloid-β Precursor Protein are Sorted to Distinct Carrier Vesicles That are Independently Transported within Neurites. J. Neurosci. 2009, 29, 3565–3578. DOI: 10.1523/JNEUROSCI.2558-08.2009.
PubMed Web of Science ®Google Scholar
Chakravarthy, B.; Gaudet, C.; Ménard, M.; Atkinson, T.; Brown, L.; LaFerla, F. M.; Armato, U.; Whitfield, J. Amyloid-β Peptides Stimulate the Expression of the p75 NTR Neurotrophin Receptor in SHSY5Y Human Neuroblastoma Cells and AD Transgenic Mice. J. Alzheimer’s Dis. 2010, 19, 915–925. DOI: 10.3233/JAD-2010-1288.
PubMed Web of Science ®Google Scholar
Hensley, K.; Venkova, K.; Christov, A.; Gunning, W.; Park, J. Collapsin Response Mediator Protein-2: An Emerging Pathologic Feature and Therapeutic Target for Neurodisease Indications. Mol. Neurobiol. 2011, 43(3), 180–191. DOI: 10.1007/s12035-011-8166-4.
PubMed Web of Science ®Google Scholar
Heneka, M. T.; Carson, M. J.; El Khoury, J.; Landreth, G. E.; Brosseron, F.; Feinstein, D. L.; Jacobs, A. H.; Wyss-Coray, T.; Vitorica, J.; Ransohoff, R. M. Neuroinflammation in Alzheimer’s Disease. Lancet. Neurol. 2015, 14, 388–405. DOI: 10.1016/S1474-4422(15)70016-5.
PubMed Web of Science ®Google Scholar
Su, L.-J.; Zhang, J.-H.; Gomez, H.; Murugan, R.; Hong, X.; Xu, D.; Jiang, F.; Peng, Z.-Y. Reactive Oxygen Species-Induced Lipid Peroxidation in Apoptosis, Autophagy, and Ferroptosis. Oxid. Med. Cell Longev. 2019, 2019, 1–13. DOI: 10.1155/2019/5080843.
Web of Science ®Google Scholar
Busche, M. A.; Hyman, B. T. Synergy Between Amyloid-β and Tau in Alzheimer’s Disease. Nat. Neurosci. 2020, 23(10), 1183–1193. DOI: 10.1038/s41593-020-0687-6.
PubMed Web of Science ®Google Scholar
Muresan, Z.; Muresan, V. Neuritic Deposits of Amyloid-β Peptide in a Subpopulation of Central Nervous System-Derived Neuronal Cells. Mol. Cell. Biol. 2006, 26, 4982–4997. DOI: 10.1128/MCB.00371-06.
PubMed Web of Science ®Google Scholar
Kanaan, N. M.; Morfini, G.; Pigino, G.; LaPointe, N. E.; Andreadis, A.; Song, Y.; Leitman, E.; Binder, L. I.; Brady, S. T. Phosphorylation in the Amino Terminus of Tau Prevents Inhibition of Anterograde Axonal Transport. Neurobiol. Aging. 2012, 33, 826–e15. DOI: 10.1016/j.neurobiolaging.2011.06.006.
Web of Science ®Google Scholar
Kumar, S.; Walter, J. Phosphorylation of Amyloid Beta (Aβ) Peptides–A Trigger for Formation of Toxic Aggregates in Alzheimer’s Disease. Aging (Albany N.Y). 2011, 3, 803. DOI: 10.18632/aging.100362.
PubMedGoogle Scholar
Morris, G. P.; Clark, I. A.; Vissel, B. Questions Concerning the Role of Amyloid-β in the Definition, Aetiology and Diagnosis of Alzheimer’s Disease. Acta. Neuropathol. 2018, 136(5), 663–689. DOI: 10.1007/s00401-018-1918-8.
PubMed Web of Science ®Google Scholar
Devanand, D. P.; Schupf, N.; Stern, Y.; Parsey, R.; Pelton, G. H.; Mehta, P.; Mayeux, R. Plasma Aβ and PET PiB Binding are Inversely Related in Mild Cognitive Impairment. Neurology. 2011, 77, 125–131. DOI: 10.1212/WNL.0b013e318224afb7.
PubMed Web of Science ®Google Scholar
Um, J. W.; Nygaard, H. B.; Heiss, J. K.; Kostylev, M. A.; Stagi, M.; Vortmeyer, A.; Wisniewski, T.; Gunther, E. C.; Strittmatter, S. M. Alzheimer Amyloid-β Oligomer Bound to Postsynaptic Prion Protein Activates Fyn to Impair Neurons. Nat. Neurosci. 2012, 15(9), 1227–1235. DOI: 10.1038/nn.3178.
PubMed Web of Science ®Google Scholar
Grundman, M.; Petersen, R. C.; Ferris, S. H.; Thomas, R. G.; Aisen, P. S.; Bennett, D. A.; Foster, N. L.; Jack, C. R., Jr; Galasko, D. R.; Doody, R. Mild Cognitive Impairment Can Be Distinguished from Alzheimer Disease and Normal Aging for Clinical Trials. Arch. Neurol. 2004, 61, 59–66. DOI: 10.1001/archneur.61.1.59.
PubMed Web of Science ®Google Scholar
Arnsten, A. F. T.; Datta, D.; Preuss, T. M. Studies of Aging Nonhuman Primates Illuminate the Etiology of Early‐Stage Alzheimer’s‐Like Neuropathology: An Evolutionary Perspective. Am. J. Primatol. 2021, 83(11), e23254. DOI: 10.1002/ajp.23254.
PubMed Web of Science ®Google Scholar
Nussbaum, L.; Hogea, L. M.; Calina, D.; Andreescu, N.; Gradinaru, R.; Stefanescu, R.; Puiu, M. Modern Treatment Approaches in Psychoses. Pharmacogenetic, Neuroimagistic and Clinical Implications. Farmacia. 2017, 65, 75–81.
Web of Science ®Google Scholar
Zucchella, C.; Sinforiani, E.; Tamburin, S.; Federico, A.; Mantovani, E.; Bernini, S.; Casale, R.; Bartolo, M. The Multidisciplinary Approach to Alzheimer’s Disease and Dementia. A Narrative Review of Non-Pharmacological Treatment. Front. Neurol. 2018, 9, 1058. DOI: 10.3389/fneur.2018.01058.
PubMed Web of Science ®Google Scholar
Calina, D.; Buga, A. M.; Mitroi, M.; Buha, A.; Caruntu, C.; Scheau, C.; Bouyahya, A.; El Omari, N.; El Menyiy, N.; Docea, A. O. The Treatment of Cognitive, Behavioural and Motor Impairments from Brain Injury and Neurodegenerative Diseases Through Cannabinoid System Modulation—Evidence from In Vivo Studies. J. Clin. Med. 2020a, 9, 2395. DOI: 10.3390/jcm9082395.
PubMed Web of Science ®Google Scholar
Sharifi-Rad, M.; Lankatillake, C.; Dias, D. A.; Docea, A. O.; Mahomoodally, M. F.; Lobine, D.; Chazot, P. L.; Kurt, B.; Boyunegmez Tumer, T.; Catarina Moreira, A. Impact of Natural Compounds on Neurodegenerative Disorders: From Preclinical to Pharmacotherapeutics. J. Clin. Med. 2020, 9(4), 1061. DOI: 10.3390/jcm9041061.
PubMed Web of Science ®Google Scholar
Atri, A. The Alzheimer’s Disease Clinical Spectrum: Diagnosis and Management. Med. Clin. North America. 2019, 103(2), 263–293. DOI: 10.1016/j.mcna.2018.10.009.
PubMed Web of Science ®Google Scholar
Howard, R.; Liu, K. Y. Questions EMERGE as Biogen Claims Aducanumab Turnaround. Nat. Rev. Neurol. 2020, 16(2), 63–64. DOI: 10.1038/s41582-019-0295-9.
PubMed Web of Science ®Google Scholar
Yiannopoulou, K. G.; Papageorgiou, S. G. Current and Future Treatments in Alzheimer Disease: An Update. J. Cent. Nerv. Syst. Dis. 2020, 12, 1179573520907397. DOI: 10.1177/1179573520907397.
Web of Science ®Google Scholar
Finn, L. A. Current Medications for the Treatment of Alzheimer’s Disease: Acetylcholinesterase Inhibitors and NMDA Receptor Antagonist, in Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders; Elsevier, 2017; pp. 49–58.
Google Scholar
Tricco, A. C.; Ashoor, H. M.; Soobiah, C.; Rios, P.; Veroniki, A. A.; Hamid, J. S.; Ivory, J. D.; Khan, P. A.; Yazdi, F.; Ghassemi, M. Comparative Effectiveness and Safety of Cognitive Enhancers for Treating Alzheimer’s Disease: Systematic Review and Network Metaanalysis. J. Am. Geriatr. Soc. 2018, 66, 170–178. DOI: 10.1111/jgs.15069.
PubMed Web of Science ®Google Scholar
Wang, R.; Reddy, P. H. Role of Glutamate and NMDA Receptors in Alzheimer’s Disease. J. Alzheimer’s Dis. 2017, 57, 1041–1048. DOI: 10.3233/JAD-160763.
PubMed Web of Science ®Google Scholar
Korábečný, J.; Nepovimova, E.; Cikankova, T.; Špilovská, K.; Vašková, L.; Mezeiova, E.; Kuča, K.; Hroudova, J. Newly Developed Drugs for Alzheimer’s Disease in Relation to Energy Metabolism, Cholinergic and Monoaminergic Neurotransmission. Neuroscience. 2018, 370, 191–206. DOI: 10.1016/j.neuroscience.2017.06.034.
PubMed Web of Science ®Google Scholar
Islam, M. S.; Quispe, C.; Hossain, R.; Islam, M. T.; Al-Harrasi, A.; Al-Rawahi, A.; Martorell, M.; Mamurova, A.; Seilkhan, A.; Altybaeva, N. Neuropharmacological Effects of Quercetin: A Literature-Based Review. Front. Pharmacol. 2021, 12, 665031. DOI: 10.3389/fphar.2021.665031.
PubMed Web of Science ®Google Scholar
Tsoukalas, D.; Zlatian, O.; Mitroi, M.; Renieri, E.; Tsatsakis, A.; Izotov, B. N.; Burada, F.; Sosoi, S.; Burada, E.; Buga, A. M. A Novel Nutraceutical Formulation Can Improve Motor Activity and Decrease the Stress Level in a Murine Model of Middle-Age Animals. J. Clin. Med. 2021b, 10(4), 624. DOI: 10.3390/jcm10040624.
PubMed Web of Science ®Google Scholar
Aronson, J. K. Defining ‘Nutraceuticals’: Neither Nutritious nor Pharmaceutical. Br.J. Clin. Pharmacol. 2017, 83(1), 8–19. DOI: 10.1111/bcp.12935.
PubMed Web of Science ®Google Scholar
Santini, A.; Cammarata, S. M.; Capone, G.; Ianaro, A.; Tenore, G. C.; Pani, L.; Novellino, E. Nutraceuticals: Opening the Debate for a Regulatory Framework. Br.J. Clin. Pharmacol. 2018, 84(4), 659–672. DOI: 10.1111/bcp.13496.
PubMed Web of Science ®Google Scholar
Ayaz, M.; Ullah, F.; Sadiq, A.; Kim, M. O.; Ali, T. Natural Products-Based Drugs: Potential Therapeutics Against Alzheimer’s Disease and Other Neurological Disorders; Frontiers Media SA, 2019a. DOI:10.3389/978-2-88963-348-7.
Google Scholar
Cassidy, L.; Fernandez, F.; Johnson, J. B.; Naiker, M.; Owoola, A. G.; Broszczak, D. A. Oxidative Stress in Alzheimer’s Disease: A Review on Emergent Natural Polyphenolic Therapeutics. Complement Ther. Med. 2020, 49, 102294. DOI: 10.1016/j.ctim.2019.102294.
PubMed Web of Science ®Google Scholar
Gustavsson, J.; Cederberg, C.; Sonesson, U.; Van Otterdijk, R.; Meybeck, A. Global food losses and food waste: Extent causes and prevention. In Extent of food losses and waste. Food and Agriculture Organization of the United Nations (FAO): Rome, Italy, 2011; pp 4–10.
Google Scholar
Sharifi-Rad, J.; Herrera-Bravo, J.; Kamiloglu, S.; Petroni, K.; Mishra, A. P.; Monserrat-Mesquida, M.; Sureda, A.; Martorell, M.; Aidarbekovna, D. S.; Yessimsiitova, Z. Recent Advances in the Therapeutic Potential of Emodin for Human Health. Biomed. Pharmacother. 2022a, 154, 113555. DOI: 10.1016/j.biopha.2022.113555.
PubMed Web of Science ®Google Scholar
Gul, K.; Singh, A. K.; Jabeen, R. Nutraceuticals and Functional Foods: The Foods for the Future World. Crit. Rev. Food Sci. Nutr. 2016, 56(16), 2617–2627. DOI: 10.1080/10408398.2014.903384.
PubMed Web of Science ®Google Scholar
Kitic, D.; Miladinovic, B.; Randjelovic, M.; Szopa, A.; Sharifi-Rad, J.; Calina, D.; Seidel, V. Anticancer Potential and Other Pharmacological Properties of Prunus armeniaca L.: An Updated Overview. Plants. 2022, 11(14), 1885. DOI: 10.3390/plants11141885.
Google Scholar
Taroncher, M.; Vila-Donat, P.; Tolosa, J.; Ruiz, M. J.; Rodríguez-Carrasco, Y. Biological Activity and Toxicity of Plant Nutraceuticals: An Overview. Curr. Opin. Food Sci. 2021, 42, 113–118. DOI: 10.1016/j.cofs.2021.05.008.
Web of Science ®Google Scholar
Almanza, A.; Carlesso, A.; Chintha, C.; Creedican, S.; Doultsinos, D.; Leuzzi, B.; Luís, A.; McCarthy, N.; Montibeller, L.; More, S. Endoplasmic Reticulum Stress Signalling–From Basic Mechanisms to Clinical Applications. FEBS J. 2019, 286(2), 241–278. DOI: 10.1111/febs.14608.
PubMed Web of Science ®Google Scholar
Kim, G. H.; Kim, J. E.; Rhie, S. J.; Yoon, S. The Role of Oxidative Stress in Neurodegenerative Diseases. Exp. Neurobiol. 2015, 24(4), 325. DOI: 10.5607/en.2015.24.4.325.
PubMed Web of Science ®Google Scholar
Reyes-Fermín, L. M.; Aparicio-Trejo, O. E.; Avila-Rojas, S. H.; Gómez-Sierra, T.; Martínez-Klimova, E.; Pedraza-Chaverri, J. Natural antioxidants’ Effects on Endoplasmic Reticulum Stress-Related Diseases. Food Chem. Toxicol. 2020, 138, 111229. DOI: 10.1016/j.fct.2020.111229.
PubMed Web of Science ®Google Scholar
Chen, X.; Drew, J.; Berney, W.; Lei, W. Neuroprotective Natural Products for Alzheimer’s Disease. Cells. 2021, 10(6), 1309. DOI: 10.3390/cells10061309.
PubMed Web of Science ®Google Scholar
Tsoukalas, D.; Buga, A. M.; Docea, A. O.; Sarandi, E.; Mitrut, R.; Renieri, E.; Spandidos, D. A.; Rogoveanu, I.; Cercelaru, L.; Niculescu, M. Reversal of Brain Aging by Targeting Telomerase: A Nutraceutical Approach. Int. J. Mol. Med. 2021a, 48(5), 1–11. DOI: 10.3892/ijmm.2021.5032.
Web of Science ®Google Scholar
Venkatesan, R.; Ji, E.; Kim, S. Y. Phytochemicals That Regulate Neurodegenerative Disease by Targeting Neurotrophins: A Comprehensive Review. Biomed Res. Int. 2015, 2015, 1–22. DOI: 10.1155/2015/814068.
Web of Science ®Google Scholar
Tsoukalas, D.; Fragkiadaki, P.; Docea, A. O.; Alegakis, A. K.; Sarandi, E.; Thanasoula, M.; Spandidos, D. A.; Tsatsakis, A.; Razgonova, M. P.; Calina, D. Discovery of Potent Telomerase Activators: Unfolding New Therapeutic and Anti-Aging Perspectives. Mol. Med. Rep. 2019, 20, 3701–3708. DOI: 10.3892/mmr.2019.10614.
PubMed Web of Science ®Google Scholar
Calina, D.; Buga, A. M.; Mitroi, M.; Buha, A.; Caruntu, C.; Scheau, C.; Bouyahya, A.; El Omari, N.; El Menyiy, N.; Docea, A. O. The Treatment of Cognitive, Behavioural and Motor Impairments from Brain Injury and Neurodegenerative Diseases Through Cannabinoid System Modulation—Evidence from In Vivo Studies. J. Clin. Med. 2020b, 9, 2395. DOI: 10.3390/jcm9082395.
PubMed Web of Science ®Google Scholar
Kwan, P.; Konno, H.; Chan, K. Y.; Baum, L. Rationale for the Development of an Alzheimer’s Disease Vaccine. Hum. Vaccin. Immunother. 2020, 16(3), 645–653. DOI: 10.1080/21645515.2019.1665453.
PubMed Web of Science ®Google Scholar
Novak, P.; Schmidt, R.; Kontsekova, E.; Kovacech, B.; Smolek, T.; Katina, S.; Fialova, L.; Prcina, M.; Parrak, V.; Dal-Bianco, P. FUNDAMANT: An Interventional 72-Week Phase 1 Follow-Up Study of AADvac1, an Active Immunotherapy Against Tau Protein Pathology in Alzheimer’s Disease. Alzheimers Res. Ther. 2018, 10, 1–16. DOI: 10.1186/s13195-018-0436-1.
PubMed Web of Science ®Google Scholar
Wang, C. Y.; Wang, P.-N.; Chiu, M.-J.; Finstad, C. L.; Lin, F.; Lynn, S.; Tai, Y.-H.; De Fang, X.; Zhao, K.; Hung, C.-H. UB-311, a Novel UBITh® Amyloid β Peptide Vaccine for Mild Alzheimer’s Disease. Alzheimer’s & Dementia: Transl. Res. Clin. Interventions. 2017a, 3, 262–272. DOI: 10.1016/j.trci.2017.03.005.
PubMedGoogle Scholar
Molina, E. P.; Pesini, P.; Sarasa‐SanJose, M.; Marcos, I.; Lacosta, A. M.; Allué, J. A.; Fandos, N.; Sarasa, M.; Boada, M.; Group, A. P. S. Safety, Tolerability and Immunogenicity of an Active Anti‐Aβ40 Vaccine (ABvac40) in Patients with Amnestic Mild Cognitive Impairment (A‐MCI) or Very Mild Alzheimer’s Disease (VM‐AD): A Randomized, Double‐Blind, Placebo‐Controlled, Phase II Trial: Human/Human Trials: Anti‐Amyloid. Alzheimer’s & Dementia. 2020, 16, e045720.
Google Scholar
Rafii, M. S.; Sol, O.; Mobley, W. C.; Delpretti, S.; Skotko, B. G.; Burke, A. D.; Sabbagh, M. N.; Yuan, S. H.; Rissman, R. A.; Pulsifer, M. Safety, Tolerability, and Immunogenicity of the ACI-24 Vaccine in Adults with Down Syndrome: A Phase 1b Randomized Clinical Trial. JAMA Neurol. 2022, 79(6), 565–574. DOI: 10.1001/jamaneurol.2022.0983.
PubMed Web of Science ®Google Scholar
Koh, S.-H.; Kwon, H. S.; Choi, S. H.; Jeong, J. H.; Na, H. R.; Lee, C. N.; Yang, Y.; Lee, A. Y.; Lee, J.-H.; Park, K. W. Efficacy and Safety of GV1001 in Patients with Moderate-To-Severe Alzheimer’s Disease Already Receiving Donepezil: A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial. Alzheimers Res. Ther. 2021, 13, 1–11. DOI: 10.1186/s13195-021-00803-w.
PubMed Web of Science ®Google Scholar
Dow, C. T.; Greenblatt, C. L.; Chan, E. D.; Dow, J. F. Evaluation of BCG Vaccination and Plasma Amyloid: A Prospective, Pilot Study with Implications for Alzheimer’s Disease. Microorganisms. 2022, 10(2), 424. DOI: 10.3390/microorganisms10020424.
PubMed Web of Science ®Google Scholar
Cacabelos, R. How Plausible is an Alzheimer’s Disease Vaccine? Expert Opin. Drug Discov. 2020, 15(1), 1–6. DOI: 10.1080/17460441.2019.1667329.
PubMed Web of Science ®Google Scholar
Farooqui, A. A. Therapeutic Potentials of Curcumin for Alzheimer Disease; Springer International Publishing, 2016. DOI:10.1007/978-3-319-15889-1.
Google Scholar
Libro, R.; Giacoppo, S.; Soundara Rajan, T.; Bramanti, P.; Mazzon, E. Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview. Molecules. 2016, 21(4), 518. DOI: 10.3390/molecules21040518.
PubMed Web of Science ®Google Scholar
Piccialli, I.; Tedeschi, V.; Caputo, L.; D’Errico, S.; Ciccone, R.; De, F. V.; Secondo, A.; Pannaccione, A. Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes. Front. Pharmacol. 2022, 13. DOI: 10.3389/fphar.2022.876614.
PubMed Web of Science ®Google Scholar
Cioanca, O.; Hritcu, L.; Mihasan, M.; Hancianu, M. Cognitive-Enhancing and Antioxidant Activities of Inhaled Coriander Volatile Oil in Amyloid β (1–42) Rat Model of Alzheimer’s Disease. Physiol. Behav. 2013, 120, 193–202. DOI: 10.1016/j.physbeh.2013.08.006.
PubMed Web of Science ®Google Scholar
Karakaya, S.; Koca, M.; Yılmaz, S. V.; Yıldırım, K.; Pınar, N. M.; Demirci, B.; Brestic, M.; Sytar, O. Molecular Docking Studies of Coumarins Isolated from Extracts and Essential Oils of Zosima Absinthifolia Link as Potential Inhibitors for Alzheimer’s Disease. Molecules. 2019, 24, 722. DOI: 10.3390/molecules24040722.
PubMed Web of Science ®Google Scholar
Arruda, M.; Viana, H.; Rainha, N.; Neng, N. R.; Rosa, J. S.; Nogueira, J. M. F.; Barreto, M. D. C. Anti-Acetylcholinesterase and Antioxidant Activity of Essential Oils from Hedychium Gardnerianum Sheppard Ex Ker-Gawl. Molecules. 2012, 17(3), 3082–3092. DOI: 10.3390/molecules17033082.
PubMed Web of Science ®Google Scholar
Ayaz, M.; Junaid, M.; Ullah, F.; Sadiq, A.; Khan, M. A.; Ahmad, W.; Shah, M. R.; Imran, M.; Ahmad, S. Comparative Chemical Profiling, Cholinesterase Inhibitions and Anti-Radicals Properties of Essential Oils from Polygonum hydropiper L: A Preliminary Anti-Alzheimer’s Study. Lipids Health Dis. 2015, 14(1), 1–12. DOI: 10.1186/s12944-015-0145-8.
PubMedGoogle Scholar
Hancianu, M.; Cioanca, O.; Mihasan, M.; Hritcu, L. Neuroprotective Effects of Inhaled Lavender Oil on Scopolamine-Induced Dementia via Anti-Oxidative Activities in Rats. Phytomedicine. 2013, 20(5), 446–452. DOI: 10.1016/j.phymed.2012.12.005.
PubMed Web of Science ®Google Scholar
Baum, L.; Lam, C. W. K.; Cheung, S.-K.-K.; Kwok, T.; Lui, V.; Tsoh, J.; Lam, L.; Leung, V.; Hui, E.; Ng, C. Six-Month Randomized, Placebo-Controlled, Double-Blind, Pilot Clinical Trial of Curcumin in Patients with Alzheimer Disease. J. Clin. Psychopharmacol. 2008, 28, 110–113. DOI: 10.1097/jcp.0b013e318160862c.
PubMed Web of Science ®Google Scholar
Turner, R. S.; Thomas, R. G.; Craft, S.; Van Dyck, C. H.; Mintzer, J.; Reynolds, B. A.; Brewer, J. B.; Rissman, R. A.; Raman, R.; Aisen, P. S. A Randomized, Double-Blind, Placebo-Controlled Trial of Resveratrol for Alzheimer Disease. Neurology. 2015, 85, 1383–1391. DOI: 10.1212/WNL.0000000000002035.
PubMed Web of Science ®Google Scholar
Kamal, Z.; Ullah, F.; Ayaz, M.; Sadiq, A.; Ahmad, S.; Zeb, A.; Hussain, A.; Imran, M. Anticholinesterse and Antioxidant Investigations of Crude Extracts, Subsequent Fractions, Saponins and Flavonoids of Atriplex Laciniata L.: Potential Effectiveness in Alzheimer’s and Other Neurological Disorders. Biol. Res. 2015, 48(1), 1–11. DOI: 10.1186/s40659-015-0011-1.
PubMedGoogle Scholar
Chen, Z.; Mao, X.; Liu, A.; Gao, X.; Chen, X.; Ye, M.; Ye, J.; Liu, P.; Xu, S.; Liu, J. Osthole, a Natural Coumarin Improves Cognitive Impairments and BBB Dysfunction After Transient Global Brain Ischemia in C57 BL/6J Mice: Involvement of Nrf2 Pathway. Neurochem. Res. 2015, 40(1), 186–194. DOI: 10.1007/s11064-014-1483-z.
PubMed Web of Science ®Google Scholar
Kaur, N.; Dhiman, M.; Perez‐Polo, J. R.; Mantha, A. K. Ginkgolide B Revamps Neuroprotective Role of Apurinic/Apyrimidinic Endonuclease 1 and Mitochondrial Oxidative Phosphorylation Against Aβ25–35‐induced Neurotoxicity in Human Neuroblastoma Cells. J. Neurosci. Res. 2015, 93, 938–947. DOI: 10.1002/jnr.23565.
PubMed Web of Science ®Google Scholar
Khan, H.; Ullah, H.; Aschner, M.; Cheang, W. S.; Akkol, E. K. Neuroprotective Effects of Quercetin in Alzheimer’s Disease. Biomolecules. 2019, 10(1), 59. DOI: 10.3390/biom10010059.
PubMed Web of Science ®Google Scholar
Kong, Z.-H.; Chen, X.; Hua, H.-P.; Liang, L.; Liu, L.-J. The Oral Pretreatment of Glycyrrhizin Prevents Surgery-Induced Cognitive Impairment in Aged Mice by Reducing Neuroinflammation and Alzheimer’s-Related Pathology via HMGB1 Inhibition. J. Mol. Neurosci. 2017, 63, 385–395. DOI: 10.1007/s12031-017-0989-7.
PubMed Web of Science ®Google Scholar
Geiser, R. J.; Chastain, S. E.; Moss, M. A. Regulation of Bace1 mRNA Expression in Alzheimer’s Disease by Green Tea Catechins and Black Tea Theaflavins. Biophys. J. 2017, 112(3), 362a. DOI: 10.1016/j.bpj.2016.11.1965.
Web of Science ®Google Scholar
Videira, R.; Castanheira, P.; Graos, M.; Resende, R.; Salgueiro, L.; Faro, C.; Cavaleiro, C. Dose-Dependent Inhibition of BACE-1 by the Monoterpenoid 2, 3, 4, 4-Tetramethyl-5-Methylenecyclopent-2-Enone in Cellular and Mouse Models of Alzheimer’s Disease. J. Nat. Prod. 2014, 77(6), 1275–1279. DOI: 10.1021/np400903w.
PubMed Web of Science ®Google Scholar
Pérez-Severiano, F.; Salvatierra-Sánchez, R.; Rodrıguez-Pérez, M.; Cuevas-Martınez, E. Y.; Guevara, J.; Limón, D.; Maldonado, P. D.; Medina-Campos, O. N.; Pedraza-Chaverrı, J.; Santamarıa, A. S-Allylcysteine Prevents Amyloid-β Peptide-Induced Oxidative Stress in Rat Hippocampus and Ameliorates Learning Deficits. Eur. J. Pharmacol. 2004, 489, 197–202. DOI: 10.1016/j.ejphar.2004.03.001.
PubMed Web of Science ®Google Scholar
Amagase, H.; Petesch, B. L.; Matsuura, H.; Kasuga, S.; Itakura, Y. Intake of Garlic and Its Bioactive Components. J. Nutr. 2001, 131(3), 955S–962S. DOI: 10.1093/jn/131.3.955S.
PubMed Web of Science ®Google Scholar
Beňová, B.; Adam, M.; Pavlíková, P.; Fischer, J. Supercritical Fluid Extraction of Piceid, Resveratrol and Emodin from Japanese Knotweed. J. Supercrit. Fluids. 2010, 51(3), 325–330. DOI: 10.1016/j.supflu.2009.10.009.
Web of Science ®Google Scholar
Ko, M. J.; Cheigh, C. I.; Cho, S. W.; Chung, M. S. Subcritical Water Extraction of Flavonol Quercetin from Onion Skin. J. Food Eng. 2011, 102(4), 327–333. DOI: 10.1016/j.jfoodeng.2010.09.008.
Web of Science ®Google Scholar
Lichtblau, D.; Berger, J. M.; Nakanishi, K. Efficient Extraction of Ginkgolides and Bilobalide from Ginkgo Biloba Leaves. J. Nat. Prod. 2002, 65(10), 1501–1504. DOI: 10.1021/np0201974.
PubMed Web of Science ®Google Scholar
Lončar, M.; Jakovljević, M.; Šubarić, D.; Pavlić, M.; Buzjak Služek, V.; Cindrić, I.; Molnar, M. Coumarins in Food and Methods of Their Determination. Foods. 2020, 9(5), 645. DOI: 10.3390/foods9050645.
PubMed Web of Science ®Google Scholar
Perva-Uzunalić, A.; Škerget, M.; Knez, Ž.; Weinreich, B.; Otto, F.; Grüner, S. Extraction of Active Ingredients from Green Tea (Camellia Sinensis): Extraction Efficiency of Major Catechins and Caffeine. Food Chem. 2006, 96(4), 597–605. DOI: 10.1016/j.foodchem.2005.03.015.
Web of Science ®Google Scholar
Priyadarsini, K. I. The Chemistry of Curcumin: From Extraction to Therapeutic Agent. Molecules. 2014, 19(12), 20091–20112. DOI: 10.3390/molecules191220091.
PubMed Web of Science ®Google Scholar
Taarji, N.; Bouhoute, M.; Fainassi, F.; Hafidi, A.; Kobayashi, I.; Neves, M. A.; Tominaga, K.; Isoda, H.; Nakajima, M. Interfacial and Emulsifying Properties of Purified Glycyrrhizin and Non-Purified Glycyrrhizin-Rich Extracts from Liquorice Root (Glycyrrhiza Glabra). Food Chem. 2021, 337, 127949. DOI: 10.1016/j.foodchem.2020.127949.
PubMed Web of Science ®Google Scholar
Ali, E. S.; Akter, S.; Ramproshad, S.; Mondal, B.; Riaz, T. A.; Islam, M. T.; Khan, I. N.; Docea, A. O.; Calina, D.; Sharifi-Rad, J. Targeting Ras-ERK Cascade by Bioactive Natural Products for Potential Treatment of Cancer: An Updated Overview. Cancer Cell Int. 2022, 22(1), 246. DOI: 10.1186/s12935-022-02666-z.
PubMed Web of Science ®Google Scholar
Salehi, B.; Quispe, C.; Chamkhi, I.; El Omari, N.; Balahbib, A.; Sharifi-Rad, J.; Bouyahya, A.; Akram, M.; Iqbal, M.; Docea, A. O. Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence. Front. Pharmacol. 2021, 11, 592654. DOI: 10.3389/fphar.2020.592654.
PubMed Web of Science ®Google Scholar
Youssif, K. A.; Haggag, E. G.; Elshamy, A. M.; Rabeh, M. A.; Gabr, N. M.; Seleem, A.; Salem, M. A.; Hussein, A. S.; Krischke, M.; Mueller, M. J., et al. Anti-Alzheimer Potential, Metabolomic Profiling and Molecular Docking of Green Synthesized Silver Nanoparticles of Lampranthus Coccineus and Malephora Lutea Aqueous Extracts. Plos One. 2019, 14(11), e0223781. DOI: 10.1371/journal.pone.0223781.
PubMed Web of Science ®Google Scholar
Suganthy, N.; Sri Ramkumar, V.; Pugazhendhi, A.; Benelli, G.; Archunan, G. Biogenic Synthesis of Gold Nanoparticles from Terminalia Arjuna Bark Extract: Assessment of Safety Aspects and Neuroprotective Potential via Antioxidant, Anticholinesterase, and Antiamyloidogenic Effects. Environ. Sci. Pollut. Res. 2018, 25(11), 10418–10433. DOI: 10.1007/s11356-017-9789-4.
PubMed Web of Science ®Google Scholar
El-Hawwary, S. S.; Abd Almaksoud, H. M.; Saber, F. R.; Elimam, H.; Sayed, A. M.; Raey, M. A. E.; Abdelmohsen, U. R. Green-Synthesized Zinc Oxide Nanoparticles, Anti-Alzheimer Potential and the Metabolic Profiling of Sabal Blackburniana Grown in Egypt Supported by Molecular Modelling. R.S.C. Adv. 2021, 11(29), 18009–18025. DOI: 10.1039/D1RA01725J.
PubMed Web of Science ®Google Scholar
Ringman, J. M.; Frautschy, S. A.; Cole, G. M.; Masterman, D. L.; Cummings, J. L. A Potential Role of the Curry Spice Curcumin in Alzheimer’s Disease. Curr. Alzheimer Res. 2005, 2, 131–136. DOI: 10.2174/1567205053585882.
PubMedGoogle Scholar
Zheng, K.; Dai, X.; Xiao, N.; Wu, X.; Wei, Z.; Fang, W.; Zhu, Y.; Zhang, J.; Chen, X. Curcumin Ameliorates Memory Decline via Inhibiting BACE1 Expression and β-Amyloid Pathology in 5× FAD Transgenic Mice. Mol. Neurobiol. 2017, 54(3), 1967–1977. DOI: 10.1007/s12035-016-9802-9.
PubMed Web of Science ®Google Scholar
Zhang, X.; Zhang, H.; Si, L.; Li, Y. Curcumin Mediates Presenilin-1 Activity to Reduce β-Amyloid Production in a Model of Alzheimer’s Disease. Pharmacol. Rep. 2011, 63, 1101–1108. DOI: 10.1016/S1734-1140(11)70629-6.
PubMed Web of Science ®Google Scholar
Carrettiero, D. C.; Hernandez, I.; Neveu, P.; Papagiannakopoulos, T.; Kosik, K. S. The Cochaperone BAG2 Sweeps Paired Helical Filament-Insoluble Tau from the Microtubule. J. Neurosci. 2009, 29, 2151–2161. DOI: 10.1523/JNEUROSCI.4660-08.2009.
PubMed Web of Science ®Google Scholar
Patil, S. P.; Tran, N.; Geekiyanage, H.; Liu, L.; Chan, C. Curcumin-Induced Upregulation of the Anti-Tau Cochaperone BAG2 in Primary Rat Cortical Neurons. Neurosci. Lett. 2013, 554, 121–125. DOI: 10.1016/j.neulet.2013.09.008.
PubMed Web of Science ®Google Scholar
Mani, R.; Sha Sulthana, A.; Muthusamy, G.; Elangovan, N. Progress in the Development of Naturally Derived Active Metabolites‐Based Drugs: Potential Therapeutics for Alzheimer’s Disease. Biotechnol. Appl. Biochem. 2022, 69, 2713–2732. DOI: 10.1002/bab.2317.
PubMed Web of Science ®Google Scholar
Tian, B.; Liu, J. Resveratrol: A Review of Plant Sources, Synthesis, Stability, Modification and Food Application. J. Sci. Food Agric. 2020, 100(4), 1392–1404. DOI: 10.1002/jsfa.10152.
PubMed Web of Science ®Google Scholar
Rahman, M.; Akter, R.; Bhattacharya, T.; Abdel-Daim, M. M.; Alkahtani, S.; Arafah, M. W.; Al-Johani, N. S.; Alhoshani, N. M.; Alkeraishan, N.; Alhenaky, A. Resveratrol and Neuroprotection: Impact and Its Therapeutic Potential in Alzheimer’s Disease. Front. Pharmacol. 2020, 2272. DOI: 10.3389/fphar.2020.619024.
Google Scholar
Wang, J.; Ho, L.; Zhao, W.; Ono, K.; Rosensweig, C.; Chen, L.; Humala, N.; Teplow, D. B.; Pasinetti, G. M. Grape-Derived Polyphenolics Prevent Aβ Oligomerization and Attenuate Cognitive Deterioration in a Mouse Model of Alzheimer’s Disease. J. Neurosci. 2008, 28, 6388–6392. DOI: 10.1523/JNEUROSCI.0364-08.2008.
PubMed Web of Science ®Google Scholar
Jeon, B. T.; Jeong, E. A.; Shin, H. J.; Lee, Y.; Lee, D. H.; Kim, H. J.; Kang, S. S.; Cho, G. J.; Choi, W. S.; Roh, G. S. Resveratrol Attenuates Obesity-Associated Peripheral and Central Inflammation and Improves Memory Deficit in Mice Fed a High-Fat Diet. Diabetes. 2012, 61(6), 1444–1454. DOI: 10.2337/db11-1498.
PubMed Web of Science ®Google Scholar
Lee, E. O.; Park, H. J.; Kang, J. L.; Kim, H.; Chong, Y. H. Resveratrol Reduces Glutamate‐Mediated Monocyte Chemotactic Protein‐1 Expression via Inhibition of Extracellular Signal‐Regulated Kinase 1/2 Pathway in Rat Hippocampal Slice Cultures. J. Neurochem. 2010, 112(6), 1477–1487. DOI: 10.1111/j.1471-4159.2009.06564.x.
PubMed Web of Science ®Google Scholar
Sarroca, S.; Gatius, A.; Rodríguez-Farré, E.; Vilchez, D.; Pallàs, M.; Griñán-Ferré, C.; Sanfeliu, C.; Corpas, R. Resveratrol Confers Neuroprotection Against High-Fat Diet in a Mouse Model of Alzheimer’s Disease via Modulation of Proteolytic Mechanisms. J. Nutr. Biochem. 2021, 89, 108569. DOI: 10.1016/j.jnutbio.2020.108569.
PubMed Web of Science ®Google Scholar
Lin, C.-H.; Lin, C.-C.; Ting, W.-J.; Pai, P.-Y.; Kuo, C.-H.; Ho, T.-J.; Kuo, W.-W.; Chang, C.-H.; Huang, C.-Y.; Lin, W.-T. Resveratrol Enhanced FOXO3 Phosphorylation via Synergetic Activation of SIRT1 and PI3K/Akt Signaling to Improve the Effects of Exercise in Elderly Rat Hearts. Age (Omaha). 2014, 36(5), 1–10. DOI: 10.1007/s11357-014-9705-5.
Google Scholar
Cheng, A.; Wan, R.; Yang, J.-L.; Kamimura, N.; Son, T. G.; Ouyang, X.; Luo, Y.; Okun, E.; Mattson, M. P. Involvement of PGC-1α in the Formation and Maintenance of Neuronal Dendritic Spines. Nat. Commun. 2012, 3(1), 1250. DOI: 10.1038/ncomms2238.
PubMedGoogle Scholar
Li, X.; Yang, S.; Wang, L.; Liu, P.; Zhao, S.; Li, H.; Jiang, Y.; Guo, Y.; Wang, X. resveratrol Inhibits Paclitaxel-Induced Neuropathic Pain by the Activation of PI3K/Akt and SIRT1/PGC1α Pathway. J. Pain Res. 2019, Volume 12, 879–890. DOI: 10.2147/JPR.S185873.
Web of Science ®Google Scholar
Wang, B.; Yang, Q.; Sun, Y.; Xing, Y.; Wang, Y.; Lu, X.; Bai, W.; Liu, X.; Zhao, Y. Resveratrol‐Enhanced Autophagic Flux Ameliorates Myocardial Oxidative Stress Injury in Diabetic Mice. J. Cell Mol. Med. 2014, 18(8), 1599–1611. DOI: 10.1111/jcmm.12312.
PubMed Web of Science ®Google Scholar
Shanbhag, S. M.; Kulkarni, H. J.; Gaitonde, B. B. Pharmacological Actions of Berberine on the Central Nervous System. Japanese J. Pharmacol. 1970, 20, 482–487. DOI: 10.1254/jjp.20.482.
PubMedGoogle Scholar
Durairajan, S. S. K.; Liu, L.-F.; Lu, J.-H.; Chen, L.-L.; Yuan, Q.; Chung, S. K.; Huang, L.; Li, X.-S.; Huang, J.-D.; Li, M. Berberine Ameliorates β-Amyloid Pathology, Gliosis, and Cognitive Impairment in an Alzheimer’s Disease Transgenic Mouse Model. Neurobiol. Aging. 2012, 33, 2903–2919. DOI: 10.1016/j.neurobiolaging.2012.02.016.
PubMed Web of Science ®Google Scholar
Ji, H.-F.; Shen, L. Molecular Basis of Inhibitory Activities of Berberine Against Pathogenic Enzymes in Alzheimer’s Disease. Sci. World J. 2012, 2012, 1–4. DOI: 10.1100/2012/823201.
Google Scholar
Cummings, J. L. Cholinesterase Inhibitors: A New Class of Psychotropic Compounds. Am. j. psychiatry. 2000, 157(1), 4–15. DOI: 10.1176/ajp.157.1.4.
PubMed Web of Science ®Google Scholar
Yu, G.; Li, Y.; Tian, Q.; Liu, R.; Wang, Q.; Wang, J.-Z.; Wang, X. Berberine Attenuates Calyculin A-Induced Cytotoxicity and Tau Hyperphosphorylation in HEK293 Cells. J. Alzheimer’s Dis. 2011, 24, 525–535. DOI: 10.3233/JAD-2011-101779.
PubMed Web of Science ®Google Scholar
de Oliveira, J. S.; Abdalla, F. H.; Dornelles, G. L.; Adefegha, S. A.; Palma, T. V.; Signor, C.; da Silva Bernardi, J.; Baldissarelli, J.; Lenz, L. S.; Magni, L. P. Berberine Protects Against Memory Impairment and Anxiogenic-Like Behavior in Rats Submitted to Sporadic Alzheimer’s-Like Dementia: Involvement of Acetylcholinesterase and Cell Death. Neurotoxicology. 2016, 57, 241–250. DOI: 10.1016/j.neuro.2016.10.008.
PubMed Web of Science ®Google Scholar
Huang, M.; Jiang, X.; Liang, Y.; Liu, Q.; Chen, S.; Guo, Y. I. Berberine Improves Cognitive Impairment by Promoting Autophagic Clearance and Inhibiting Production of β-Amyloid in APP/Tau/PS1 Mouse Model of Alzheimer’s Disease. Exp. Gerontol. 2017, 91, 25–33. DOI: 10.1016/j.exger.2017.02.004.
PubMed Web of Science ®Google Scholar
Ay, M.; Luo, J.; Langley, M.; Jin, H.; Anantharam, V.; Kanthasamy, A.; Kanthasamy, A. G. Molecular Mechanisms Underlying Protective Effects of Quercetin Against Mitochondrial Dysfunction and Progressive Dopaminergic Neurodegeneration in Cell Culture and MitoPark Transgenic Mouse Models of Parkinson’s Disease. J. Neurochem. 2017, 141, 766–782. DOI: 10.1111/jnc.14033.
PubMed Web of Science ®Google Scholar
Jiang, W.; Luo, T.; Li, S.; Zhou, Y.; Shen, X.-Y.; He, F.; Xu, J.; Wang, H.-Q.; Arai, K. Quercetin Protects Against Okadaic Acid-Induced Injury via MAPK and PI3K/Akt/GSK3β Signaling Pathways in HT22 Hippocampal Neurons. Plos One. 2016, 11(4), e0152371. DOI: 10.1371/journal.pone.0152371.
PubMed Web of Science ®Google Scholar
Qureshi, A. A.; Tan, X.; Reis, J. C.; Badr, M. Z.; Papasian, C. J.; Morrison, D. C.; Qureshi, N. Inhibition of Nitric Oxide in LPS-Stimulated Macrophages of Young and Senescent Mice by δ-Tocotrienol and Quercetin. Lipids Health Dis. 2011, 10(1), 1–22. DOI: 10.1186/1476-511X-10-239.
Google Scholar
Rezai-Zadeh, K.; Arendash, G. W.; Hou, H.; Fernandez, F.; Jensen, M.; Runfeldt, M.; Shytle, R. D.; Tan, J. Green Tea Epigallocatechin-3-Gallate (EGCG) Reduces β-Amyloid Mediated Cognitive Impairment and Modulates Tau Pathology in Alzheimer Transgenic Mice. Brain. Res. 2008a, 1214, 177–187. DOI: 10.1016/j.brainres.2008.02.107.
PubMed Web of Science ®Google Scholar
Rezai-Zadeh, K.; Shytle, D.; Sun, N.; Mori, T.; Hou, H.; Jeanniton, D.; Ehrhart, J.; Townsend, K.; Zeng, J.; Morgan, D. Green Tea Epigallocatechin-3-Gallate (EGCG) Modulates Amyloid Precursor Protein Cleavage and Reduces Cerebral Amyloidosis in Alzheimer Transgenic Mice. J. Neurosci. 2005, 25, 8807–8814. DOI: 10.1523/JNEUROSCI.1521-05.2005.
PubMed Web of Science ®Google Scholar
Singh, M.; Arseneault, M.; Sanderson, T.; Murthy, V.; Ramassamy, C. Challenges for Research on Polyphenols from Foods in Alzheimer’s Disease: Bioavailability, Metabolism, and Cellular and Molecular Mechanisms. J. Agric. Food. Chem. 2008, 56(13), 4855–4873. DOI: 10.1021/jf0735073.
PubMed Web of Science ®Google Scholar
Mandel, S.; Amit, T.; Reznichenko, L.; Weinreb, O.; Youdim, M. B. H. Green Tea Catechins as Brain‐Permeable, Natural Iron Chelators‐Antioxidants for the Treatment of Neurodegenerative Disorders. Mol. Nutr Food Res. 2006, 50, 229–234. DOI: 10.1002/mnfr.200500156.
PubMed Web of Science ®Google Scholar
Chen, C.; Yu, R.; Owuor, E. D.; Tony Kong, A.-N. Activation of Antioxidant-Response Element (ARE), Mitogen-Activated Protein Kinases (MAPKs) and Caspases by Major Green Tea Polyphenol Components During Cell Survival and Death. Arch. Pharm. Res. 2000, 23, 605–612. DOI: 10.1007/BF02975249.
PubMed Web of Science ®Google Scholar
Ishige, K.; Schubert, D.; Sagara, Y. Flavonoids Protect Neuronal Cells from Oxidative Stress by Three Distinct Mechanisms. Free Radic. Biol. Med. 2001, 30(4), 433–446. DOI: 10.1016/S0891-5849(00)00498-6.
PubMed Web of Science ®Google Scholar
Levites, Y.; Amit, T.; Mandel, S.; Youdim, M. B. H. Neuroprotection and Neurorescue Against Aβ Toxicity and PKC‐Dependent Release of Non‐Amyloidogenic Soluble Precursor Protein by Green Tea Polyphenol (‐)‐Epigallocatechin‐3‐Gallate. FASEB. J. 2003, 17, 1–23. DOI: 10.1096/fj.02-0881fje.
PubMedGoogle Scholar
Bastianetto, S.; Yao, Z.; Papadopoulos, V.; Quirion, R. Neuroprotective Effects of Green and Black Teas and Their Catechin Gallate Esters Against β‐Amyloid‐Induced Toxicity. European J. Neurosci. 2006, 23(1), 55–64. DOI: 10.1111/j.1460-9568.2005.04532.x.
PubMed Web of Science ®Google Scholar
Obregon, D. F.; Rezai-Zadeh, K.; Bai, Y.; Sun, N.; Hou, H.; Ehrhart, J.; Zeng, J.; Mori, T.; Arendash, G. W.; Shytle, D. ADAM10 Activation is Required for Green Tea (–)-epigallocatechin-3-gallate-induced α-Secretase Cleavage of Amyloid Precursor Protein. J. Biol. Chem. 2006, 281(24), 16419–16427. DOI: 10.1074/jbc.M600617200.
PubMed Web of Science ®Google Scholar
Jeon, S.-Y.; Bae, K.; Seong, Y.-H.; Song, K.-S. Green Tea Catechins as a BACE1 (β-Secretase) Inhibitor. Bioorg. Med. Chem. Lett. 2003, 13(22), 3905–3908. DOI: 10.1016/j.bmcl.2003.09.018.
PubMed Web of Science ®Google Scholar
Ono, K.; Hasegawa, K.; Naiki, H.; Yamada, M. Curcumin Has Potent Anti‐Amyloidogenic Effects for Alzheimer’s β‐Amyloid Fibrils In Vitro. J. Neurosci. Res. 2004, 75, 742–750. DOI: 10.1002/jnr.20025.
PubMed Web of Science ®Google Scholar
Ehrnhoefer, D. E.; Bieschke, J.; Boeddrich, A.; Herbst, M.; Masino, L.; Lurz, R.; Engemann, S.; Pastore, A.; Wanker, E. E. EGCG Redirects Amyloidogenic Polypeptides into Unstructured, Off-Pathway Oligomers. Nat. Struct. Mol. Biol. 2008, 15(6), 558–566. DOI: 10.1038/nsmb.1437.
PubMed Web of Science ®Google Scholar
Zhao, B.; Li, X.; He, R.; Cheng, S.; Wenjuan, X. Scavenging Effect of Extracts of Green Tea and Natural Antioxidants on Active Oxygen Radicals. Cell Biophys. 1989, 14, 175–185. DOI: 10.1007/BF02797132.
PubMedGoogle Scholar
Choi, Y.-T.; Jung, C.-H.; Lee, S.-R.; Bae, J.-H.; Baek, W.-K.; Suh, M.-H.; Park, J.; Park, C.-W.; Suh, S.-I. The Green Tea Polyphenol (−)-Epigallocatechin Gallate Attenuates β-Amyloid-Induced Neurotoxicity in Cultured Hippocampal Neurons. Life. sci. 2001, 70(5), 603–614. DOI: 10.1016/S0024-3205(01)01438-2.
PubMed Web of Science ®Google Scholar
Haque, A. M.; Hashimoto, M.; Katakura, M.; Hara, Y.; Shido, O. Green Tea Catechins Prevent Cognitive Deficits Caused by Aβ1–40 in Rats. J. Nutr Biochem. 2008, 19(9), 619–626. DOI: 10.1016/j.jnutbio.2007.08.008.
PubMed Web of Science ®Google Scholar
Kim, S.-J.; Jeong, H.-J.; Lee, K.-M.; Myung, N.-Y.; An, N.-H.; Yang, W. M.; Park, S. K.; Lee, H.-J.; Hong, S.-H.; Kim, H.-M. Epigallocatechin-3-Gallate Suppresses NF-Κb Activation and Phosphorylation of p38 MAPK and JNK in Human Astrocytoma U373MG Cells. J. Nutr Biochem. 2007, 18(9), 587–596. DOI: 10.1016/j.jnutbio.2006.11.001.
PubMed Web of Science ®Google Scholar
Ahmed, S.; Rahman, A.; Hasnain, A.; Lalonde, M.; Goldberg, V. M.; Haqqi, T. M. Green Tea Polyphenol Epigallocatechin-3-Gallate Inhibits the IL-1β-Induced Activity and Expression of Cyclooxygenase-2 and Nitric Oxide Synthase-2 in Human Chondrocytes. Free Radic. Biol. Med. 2002, 33(8), 1097–1105. DOI: 10.1016/S0891-5849(02)01004-3.
PubMed Web of Science ®Google Scholar
Han, M.-K. Epigallocatechin Gallate, a Constituent of Green Tea, Suppresses Cytokine-Induced Pancreatic β-Cell Damage. Exp. Mol. Med. 2003, 35(2), 136–139. DOI: 10.1038/emm.2003.19.
PubMed Web of Science ®Google Scholar
Rezai-Zadeh, K.; Arendash, G. W.; Hou, H.; Fernandez, F.; Jensen, M.; Runfeldt, M.; Shytle, R. D.; Tan, J. Green Tea Epigallocatechin-3-Gallate (EGCG) Reduces β-Amyloid Mediated Cognitive Impairment and Modulates Tau Pathology in Alzheimer Transgenic Mice. Brain. Res. 2008b, 1214, 177–187. DOI: 10.1016/j.brainres.2008.02.107.
PubMed Web of Science ®Google Scholar
Palermo, C. M.; Westlake, C. A.; Gasiewicz, T. A. Epigallocatechin Gallate Inhibits Aryl Hydrocarbon Receptor Gene Transcription Through an Indirect Mechanism Involving Binding to a 90 kDa Heat Shock Protein. Biochemistry. 2005, 44(13), 5041–5052. DOI: 10.1021/bi047433p.
PubMed Web of Science ®Google Scholar
Lee, S.-Y.; Kim, C.-Y.; Lee, J.-J.; Jung, J.-G.; Lee, S.-R. Effects of Delayed Administration of (−)-Epigallocatechin Gallate, a Green Tea Polyphenol on the Changes in Polyamine Levels and Neuronal Damage After Transient Forebrain Ischemia in Gerbils. Brain Res. Bull. 2003, 61(4), 399–406. DOI: 10.1016/S0361-9230(03)00139-4.
PubMed Web of Science ®Google Scholar
Matsuoka, Y.; Hasegawa, H.; Okuda, S.; Muraki, T.; Uruno, T.; Kubota, K. Ameliorative Effects of Tea Catechins on Active Oxygen-Related Nerve Cell Injuries. J. Pharmacol. Exp. Ther. 1995, 274, 602–608.
PubMed Web of Science ®Google Scholar
Shekarchi, M.; Hajimehdipoor, H.; Saeidnia, S.; Gohari, A. R.; Hamedani, M. P. Comparative Study of Rosmarinic Acid Content in Some Plants of Labiatae Family. Pharmacogn. Mag. 2012, 8, 37. DOI: 10.4103/0973-1296.93316.
PubMed Web of Science ®Google Scholar
Baba, S.; Osakabe, N.; Natsume, M.; Terao, J. Orally Administered Rosmarinic Acid is Present as the Conjugated And/Or Methylated Forms in Plasma, and is Degraded and Metabolized to Conjugated Forms of Caffeic Acid, Ferulic Acid and M-Coumaric Acid. Life. sci. 2004, 75(2), 165–178. DOI: 10.1016/j.lfs.2003.11.028.
PubMed Web of Science ®Google Scholar
Nakazawa, T.; Ohsawa, K. Metabolism of Rosmarinic Acid in Rats. J. Nat. Prod. 1998, 61(8), 993–996. DOI: 10.1021/np980072s.
PubMed Web of Science ®Google Scholar
Iuvone, T.; De Filippis, D.; Esposito, G.; D’Amico, A.; Izzo, A. A. The Spice Sage and Its Active Ingredient Rosmarinic Acid Protect PC12 Cells from Amyloid-β Peptide-Induced Neurotoxicity. J. Pharmacol. Exp. Ther. 2006, 317, 1143–1149. DOI: 10.1124/jpet.105.099317.
PubMed Web of Science ®Google Scholar
Airoldi, C.; Sironi, E.; Dias, C.; Marcelo, F.; Martins, A.; Rauter, A. P.; Nicotra, F.; Jimenez‐Barbero, J. Natural Compounds Against Alzheimer’s Disease: Molecular Recognition of Aβ1-42 Peptide by Salvia Sclareoides Extract and Its Major Component, Rosmarinic Acid, as Investigated by NMR. Chem.–An Asian J. 2013, 8(3), 596–602. DOI: 10.1002/asia.201201063.
PubMed Web of Science ®Google Scholar
Alkam, T.; Nitta, A.; Mizoguchi, H.; Itoh, A.; Nabeshima, T. A Natural Scavenger of Peroxynitrites, Rosmarinic Acid, Protects Against Impairment of Memory Induced by Aβ25–35. Behav. Brain Res. 2007, 180(2), 139–145. DOI: 10.1016/j.bbr.2007.03.001.
PubMed Web of Science ®Google Scholar
Bulgakov, V. P.; Inyushkina, Y. V.; Fedoreyev, S. A. Rosmarinic Acid and Its Derivatives: Biotechnology and Applications. Crit. Rev. Biotechnol. 2012, 32(3), 203–217. DOI: 10.3109/07388551.2011.596804.
PubMed Web of Science ®Google Scholar
Shukla, S.; Gupta, S. Apigenin: A Promising Molecule for Cancer Prevention. Pharm. Res. 2010, 27(6), 962–978. DOI: 10.1007/s11095-010-0089-7.
PubMed Web of Science ®Google Scholar
Hollman, P. H.; Katan, M. B. Dietary Flavonoids: Intake, Health Effects and Bioavailability. Food Chem. Toxicol. 1999, 37, 937–942. DOI: 10.1016/S0278-6915(99)00079-4.
PubMed Web of Science ®Google Scholar
Zhang, J.; Liu, D.; Huang, Y.; Gao, Y.; Qian, S. Biopharmaceutics Classification and Intestinal Absorption Study of Apigenin. Int. J. Pharm. 2012, 436(1–2), 311–317. DOI: 10.1016/j.ijpharm.2012.07.002.
PubMedGoogle Scholar
Gradolatto, A.; Canivenc-Lavier, M.-C.; Basly, J.-P.; Siess, M.-H.; Teyssier, C. Metabolism of Apigenin by Rat Liver Phase I and Phase II Enzymes and by Isolated Perfused Rat Liver. Drug Metab. Dispos. 2004, 32(1), 58–65. DOI: 10.1124/dmd.32.1.58.
PubMed Web of Science ®Google Scholar
Zhao, L.; Hou, L.; Sun, H.; Yan, X.; Sun, X.; Li, J.; Bian, Y.; Chu, Y.; Liu, Q. Apigenin Isolated from the Medicinal Plant Elsholtzia Rugulosa Prevents β-Amyloid 25–35-induces Toxicity in Rat Cerebral Microvascular Endothelial Cells. Molecules. 2011, 16(5), 4005–4019. DOI: 10.3390/molecules16054005.
Web of Science ®Google Scholar
Liu, R.; Zhang, T.; Yang, H.; Lan, X.; Ying, J.; Du, G. The Flavonoid Apigenin Protects Brain Neurovascular Coupling Against Amyloid-β 25-35-Induced Toxicity in Mice. J. Alzheimer’s Dis. 2011b, 24(1), 85–100. DOI: 10.3233/JAD-2010-101593.
PubMed Web of Science ®Google Scholar
Zhao, Y.; Zhao, B. Oxidative Stress and the Pathogenesis of Alzheimer’s Disease. Oxid. Med. Cell Longev. 2013, 2013, 1–10. DOI: 10.1155/2013/316523.
Web of Science ®Google Scholar
López-Lázaro, M. Distribution and Biological Activities of the Flavonoid Luteolin. Mini. Rev. Med. Chem. 2009, 9(1), 31–59. DOI: 10.2174/138955709787001712.
PubMed Web of Science ®Google Scholar
Shimoi, K.; Okada, H.; Furugori, M.; Goda, T.; Takase, S.; Suzuki, M.; Hara, Y.; Yamamoto, H.; Kinae, N. Intestinal Absorption of Luteolin and Luteolin 7-O-β-Glucoside in Rats and Humans. FEBS Lett. 1998, 438(3), 220–224. DOI: 10.1016/S0014-5793(98)01304-0.
PubMed Web of Science ®Google Scholar
Cheng, H.; Hsieh, M.; Tsai, F.; Wu, C.; Chiu, C.; Lee, M.; Xu, H.; Zhao, Z.; Peng, W. Neuroprotective Effect of Luteolin on Amyloid β Protein (25–35)‐induced Toxicity in Cultured Rat Cortical Neurons. Phytotherapy Res. 2010, 24, S102–S108. DOI: 10.1002/ptr.2940.
PubMed Web of Science ®Google Scholar
Wruck, C. J.; Claussen, M.; Fuhrmann, G.; Römer, L.; Schulz, A.; Pufe, T.; Waetzig, V.; Peipp, M.; Herdegen, T.; Götz, M. E. Luteolin Protects Rat PC 12 and C6 Cells Against MPP+ Induced Toxicity via an ERK Dependent Keapl-Nrf2-ARE Pathway; Springer, 2007. DOI:10.1007/978-3-211-73574-9_9.
Google Scholar
Liu, R.; Meng, F.; Zhang, L.; Liu, A.; Qin, H.; Lan, X.; Li, L.; Du, G. Luteolin Isolated from the Medicinal Plant Elsholtzia Rugulosa (Labiatae) Prevents Copper-Mediated Toxicity in β-Amyloid Precursor Protein Swedish Mutation Overexpressing SH-SY5Y Cells. Molecules. 2011a, 16(3), 2084–2096. DOI: 10.3390/molecules16032084.
PubMed Web of Science ®Google Scholar
Xu, B.; Li, X.-X.; He, G.-R.; Hu, J.-J.; Mu, X.; Tian, S.; Du, G.-H. Luteolin Promotes Long-Term Potentiation and Improves Cognitive Functions in Chronic Cerebral Hypoperfused Rats. Eur. J. Pharmacol. 2010, 627(1–3), 99–105. DOI: 10.1016/j.ejphar.2009.10.038.
PubMed Web of Science ®Google Scholar
Rasul, A.; Millimouno, F. M.; Ali Eltayb, W.; Ali, M.; Li, J.; Li, X. Pinocembrin: A Novel Natural Compound with Versatile Pharmacological and Biological Activities. Biomed Res. Int. 2013, 2013, 1–9. DOI: 10.1155/2013/379850.
Web of Science ®Google Scholar
Guo, W.-W.; Qiu, F.; Chen, X.-Q.; Ba, Y.-Y.; Wang, X.; Wu, X. In-Vivo Absorption of Pinocembrin-7-O-β-D-Glucoside in Rats and Its in-Vitro Biotransformation. Sci. Rep. 2016, 6(1), 1–8. DOI: 10.1038/srep29340.
PubMed Web of Science ®Google Scholar
Wang, Y.; Miao, Y.; Mir, A. Z.; Cheng, L.; Wang, L.; Zhao, L.; Cui, Q.; Zhao, W.; Wang, H. Inhibition of Beta-Amyloid-Induced Neurotoxicity by Pinocembrin Through Nrf2/HO-1 Pathway in SH-SY5Y Cells. J. Neurol. Sci. 2016, 368, 223–230. DOI: 10.1016/j.jns.2016.07.010.
PubMed Web of Science ®Google Scholar
Liu, R.; Wu, C.; Zhou, D.; Yang, F.; Tian, S.; Zhang, L.; Zhang, T.; Du, G. Pinocembrin Protects Against β-Amyloid-Induced Toxicity in Neurons Through Inhibiting Receptor for Advanced Glycation End Products (RAGE)-Independent Signaling Pathways and Regulating Mitochondrion-Mediated Apoptosis. BMC Med. 2012, 10(1), 1–21. DOI: 10.1186/1741-7015-10-105.
PubMedGoogle Scholar
Liu, R.; Li, J.; Song, J.; Sun, J.; Li, Y.; Zhou, S.; Zhang, T.; Du, G. Pinocembrin Protects Human Brain Microvascular Endothelial Cells Against Fibrillar Amyloid-β1− 40 Injury by Suppressing the MAPK/NF-κ B Inflammatory Pathways. Biomed Res. Int. 2014, 2014, 1–14. DOI: 10.1155/2014/470393.
Web of Science ®Google Scholar
Shi, C.; Wu, F.; Xu, J.; Zou, J. Bilobalide Regulates Soluble Amyloid Precursor Protein Release via Phosphatidyl Inositol 3 Kinase-Dependent Pathway. Neurochem. Int. 2011, 59, 59–64. DOI: 10.1016/j.neuint.2011.03.028.
PubMed Web of Science ®Google Scholar
Tchantchou, F.; Lacor, P. N.; Cao, Z.; Lao, L.; Hou, Y.; Cui, C.; Klein, W. L.; Luo, Y. Stimulation of Neurogenesis and Synaptogenesis by Bilobalide and Quercetin via Common Final Pathway in Hippocampal Neurons. J. Alzheimer’s Dis. 2009, 18, 787–798. DOI: 10.3233/JAD-2009-1189.
PubMed Web of Science ®Google Scholar
Bastianetto, S.; Ramassamy, C.; Doré, S.; Christen, Y.; Poirier, J.; Quirion, R. The Ginkgo Biloba Extract (EGb 761) Protects Hippocampal Neurons Against Cell Death Induced by β‐Amyloid. European J. Neurosci. 2000, 12(6), 1882–1890. DOI: 10.1046/j.1460-9568.2000.00069.x.
PubMed Web of Science ®Google Scholar
Longpré, F.; Garneau, P.; Ramassamy, C. Protection by EGb 761 Against β-Amyloid-Induced Neurotoxicity: Involvement of NF-κB, SIRT1, and MAPKs Pathways and Inhibition of Amyloid Fibril Formation. Free Radic. Biol. Med. 2006, 41, 1781–1794. DOI: 10.1016/j.freeradbiomed.2006.08.015.
PubMed Web of Science ®Google Scholar
Wu, Y.; Wu, Z.; Butko, P.; Christen, Y.; Lambert, M. P.; Klein, W. L.; Link, C. D.; Luo, Y. Amyloid-β-Induced Pathological Behaviors are Suppressed by Ginkgo Biloba Extract EGb 761 and Ginkgolides in Transgenic Caenorhabditis Elegans. J. Neurosci. 2006, 26, 13102–13113. DOI: 10.1523/JNEUROSCI.3448-06.2006.
PubMed Web of Science ®Google Scholar
Zhou, L.-J.; Zhu, X.-Z. Reactive Oxygen Species-Induced Apoptosis in PC12 Cells and Protective Effect of Bilobalide. J. Pharmacol. Exp. Ther. 2000, 293, 982–988.
PubMed Web of Science ®Google Scholar
Block, E. The Chemistry of Garlic and Onions. Sci. Am. 1985, 252, 114–121. DOI: 10.1038/scientificamerican0385-114.
PubMed Web of Science ®Google Scholar
Selassie, M.; Griffin, B.; Gwebu, N.; Gwebu, E. T. Aged Garlic Extract Attenuates the Cytotoxicity of (Beta-Amyloid) on Undifferentiated PC12 Cells. Vitro Cell. Dev. Biol. 1999, 35, 369. DOI: 10.1007/s11626-999-0109-2.
Web of Science ®Google Scholar
Peng, Q.; Buz’zard, A. R.; Lau, B. H. S. Neuroprotective Effect of Garlic Compounds in Amyloid-Beta Peptide-Induced Apoptosis In Vitro. Med. Sci. Monit. 2002, 8, BR328–37.
PubMedGoogle Scholar
Gupta, V. B.; Indi, S. S.; Rao, K. S. J. Garlic Extract Exhibits Antiamyloidogenic Activity on Amyloid‐Beta Fibrillogenesis: Relevance to Alzheimer’s Disease. Phytother. Res. 2009, 23, 111–115. DOI: 10.1002/ptr.2574.
PubMed Web of Science ®Google Scholar
Nillert, N.; Pannangrong, W.; Welbat, J. U.; Chaijaroonkhanarak, W.; Sripanidkulchai, K.; Sripanidkulchai, B. Neuroprotective Effects of Aged Garlic Extract on Cognitive Dysfunction and Neuroinflammation Induced by β-Amyloid in Rats. Nutrients. 2017, 9(1), 24. DOI: 10.3390/nu9010024.
PubMed Web of Science ®Google Scholar
Alshehri, M. M.; Quispe, C.; Herrera-Bravo, J.; Sharifi-Rad, J.; Tutuncu, S.; Aydar, E. F.; Topkaya, C.; Mertdinc, Z.; Ozcelik, B.; Aital, M. A Review of Recent Studies on the Antioxidant and Anti-Infectious Properties of Senna Plants. Oxid. Med. Cell Longev. 2022, 2022, 1–38. DOI: 10.1155/2022/6025900.
Web of Science ®Google Scholar
Poprac, P.; Jomova, K.; Simunkova, M.; Kollar, V.; Rhodes, C. J.; Valko, M. Targeting Free Radicals in Oxidative Stress-Related Human Diseases. Trends Pharmacol. Sci. 2017, 38(7), 592–607. DOI: 10.1016/j.tips.2017.04.005.
PubMed Web of Science ®Google Scholar
Zhang, J.; Duan, D.; Song, Z.; Liu, T.; Hou, Y.; Fang, J. Small Molecules Regulating Reactive Oxygen Species Homeostasis for Cancer Therapy. Med. Res. Rev. 2021, 41(1), 342–394. DOI: 10.1002/med.21734.
PubMed Web of Science ®Google Scholar
Sharifi-Rad, J.; Rapposelli, S.; Sestito, S.; Herrera-Bravo, J.; Arancibia-Diaz, A.; Salazar, L. A.; Yeskaliyeva, B.; Beyatli, A.; Leyva-Gómez, G.; González-Contreras, C. Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation. J. Pers. Med. 2022c, 12, 1515. DOI: 10.3390/jpm12091515.
PubMed Web of Science ®Google Scholar
Escobar, S. J. D. M.; Fong, G. M.; Winnischofer, S. M. B.; Simone, M.; Munoz, L.; Dennis, J. M.; Rocha, M. E. M.; Witting, P. K. Anti-Proliferative and Cytotoxic Activities of the Flavonoid Isoliquiritigenin in the Human Neuroblastoma Cell Line SH-SY5Y. Chem. Biol. Interact. 2019, 299, 77–87. DOI: 10.1016/j.cbi.2018.11.022.
PubMed Web of Science ®Google Scholar
Amin, R.; Quispe, C.; Docea, A. O.; Alibek, Y.; Kulbayeva, M.; Daştan, S. D.; Calina, D.; Sharifi-Rad, J. The Role of Tumour Necrosis Factor in Neuroinflammation Associated with Parkinson’s Disease and Targeted Therapies. Neurochem. Int. 2022, 158, 105376. DOI: 10.1016/j.neuint.2022.105376.
PubMed Web of Science ®Google Scholar
Taheri, Y.; Quispe, C.; Herrera-Bravo, J.; Sharifi-Rad, J.; Ezzat, S. M.; Merghany, R. M.; Shaheen, S.; Azmi, L.; Prakash Mishra, A.; Sener, B., et al. Urtica Dioica-Derived Phytochemicals for Pharmacological and Therapeutic Applications. Evid. Based Complement. Altern. Med. 2022, 2022, 1–30. DOI: 10.1155/2022/4024331.
Web of Science ®Google Scholar
Behl, C.; Moosmann, B. Oxidative Nerve Cell Death in Alzheimer's Disease and Stroke: Antioxidants as Neuroprotective Compounds. Biol. Chem. 2002, 383(3–4). DOI: 10.1515/BC.2002.053.
PubMed Web of Science ®Google Scholar
Dhyani, P.; Quispe, C.; Sharma, E.; Bahukhandi, A.; Sati, P.; Attri, D. C.; Szopa, A.; Sharifi-Rad, J.; Docea, A. O.; Mardare, I. Anticancer Potential of Alkaloids: A Key Emphasis to Colchicine, Vinblastine, Vincristine, Vindesine, Vinorelbine and Vincamine. Cancer Cell Int. 2022, 22(1), 1–20. DOI: 10.1186/s12935-022-02624-9.
PubMed Web of Science ®Google Scholar
Suganthy, N.; Devi, K. P. Protective Effect of Catechin Rich Extract of Rhizophora Mucronata Against β-Amyloid-Induced Toxicity in PC12 Cells. J. Appl. Biomed. 2016, 14(2), 137–146. DOI: 10.1016/j.jab.2015.10.003.
Web of Science ®Google Scholar
Ide, K.; Matsuoka, N.; Yamada, H.; Furushima, D.; Kawakami, K. Effects of Tea Catechins on Alzheimer’s Disease: Recent Updates and Perspectives. Molecules. 2018, 23(9), 2357. DOI: 10.3390/molecules23092357.
PubMed Web of Science ®Google Scholar
Okello, E. J.; Mather, J. Comparative Kinetics of Acetyl-And Butyryl-Cholinesterase Inhibition by Green Tea Catechins| Relevance to the Symptomatic Treatment of Alzheimer’s Disease. Nutrients. 2020, 12, 1090. DOI: 10.3390/nu12041090.
PubMed Web of Science ®Google Scholar
Ayaz, M.; Ullah, F.; Sadiq, A.; Kim, M. O.; Ali, T. Natural Products-Based Drugs: Potential Therapeutics Against Alzheimer’s Disease and Other Neurological Disorders; Frontiers Media SA, 2019b. DOI:10.3389/978-2-88963-348-7.
Google Scholar
Chougle, S.; Kumar, D.; Andleeb, K.; Zehra, S.; Ahmad, A. L. İ. Treatment of Alzheimer’s Disease by Natural Products. J. Exp. Clin. Med. 2021, 38, 634–644. DOI: 10.52142/omujecm.38.4.42.
Google Scholar
Vecchio, I.; Sorrentino, L.; Paoletti, A.; Marra, R.; Arbitrio, M. The State of the Art on Acetylcholinesterase Inhibitors in the Treatment of Alzheimer’s Disease. J. Cent. Nerv. Syst. Dis. 2021, 13, 11795735211029112. DOI: 10.1177/11795735211029113.
Web of Science ®Google Scholar
Cai, Z.; Wang, C.; Yang, W. Role of Berberine in Alzheimer’s Disease. Neuropsychiatr. Dis. Treat. 2016, 2509–2520. DOI: 10.2147/NDT.S114846.
PubMedGoogle Scholar
Yuan, N.-N.; Cai, C.-Z.; Wu, M.-Y.; Su, H.-X.; Li, M.; Lu, J.-H. Neuroprotective Effects of Berberine in Animal Models of Alzheimer’s Disease: A Systematic Review of Pre-Clinical Studies. BMC Complement. Altern. Med. 2019, 19(1), 1–10. DOI: 10.1186/s12906-019-2510-z.
PubMedGoogle Scholar
Giacomeli, R.; Izoton, J. C.; Dos Santos, R. B.; Boeira, S. P.; Jesse, C. R.; Haas, S. E. Neuroprotective Effects of Curcumin Lipid-Core Nanocapsules in a Model Alzheimer’s Disease Induced by β-Amyloid 1-42 Peptide in Aged Female Mice. Brain. Res. 2019, 1721, 146325. DOI: 10.1016/j.brainres.2019.146325.
PubMed Web of Science ®Google Scholar
Wu, P.; Li, B.; Yu, Y.; Su, P.; Liu, X.; Zhang, Z.; Zhi, D.; Qi, F.; Fei, D.; Zhang, Z. Isolation, Characterization, and Possible Anti‐Alzheimer’s Disease Activities of Bisabolane‐Type Sesquiterpenoid Derivatives and Phenolics from the Rhizomes of Curcuma Longa. Chem. Biodivers. 2020, 17, e2000067. DOI: 10.1002/cbdv.202000067.
PubMed Web of Science ®Google Scholar
Seo, E.-J.; Fischer, N.; Efferth, T. Phytochemicals as Inhibitors of NF-Κb for Treatment of Alzheimer’s Disease. Pharmacol. Res. 2018, 129, 262–273. DOI: 10.1016/j.phrs.2017.11.030.
PubMed Web of Science ®Google Scholar
Gomes, B. A. Q.; Silva, J. P. B.; Romeiro, C. F. R.; Dos Santos, S. M.; Rodrigues, C. A.; Gonçalves, P. R.; Sakai, J. T.; Mendes, P. F. S.; Varela, E. L. P.; Monteiro, M. C. Neuroprotective Mechanisms of Resveratrol in Alzheimer’s Disease: Role of SIRT1. Oxid. Med. Cell Longev. 2018, 2018, 1–15. DOI: 10.1155/2018/8152373.
Web of Science ®Google Scholar
Yamakawa, M. Y.; Uchino, K.; Watanabe, Y.; Adachi, T.; Nakanishi, M.; Ichino, H.; Hongo, K.; Mizobata, T.; Kobayashi, S.; Nakashima, K. Anthocyanin Suppresses the Toxicity of Aβ Deposits Through Diversion of Molecular Forms in In Vitro and In Vivo Models of Alzheimer’s Disease. Nutr. Neurosci. 2016, 19(1), 32–42. DOI: 10.1179/1476830515Y.0000000042.
PubMed Web of Science ®Google Scholar
Ali, T.; Kim, T.; Rehman, S. U.; Khan, M. S.; Amin, F. U.; Khan, M.; Ikram, M.; Kim, M. O. Natural Dietary Supplementation of Anthocyanins via PI3K/Akt/Nrf2/HO-1 Pathways Mitigate Oxidative Stress, Neurodegeneration, and Memory Impairment in a Mouse Model of Alzheimer’s Disease. Mol. Neurobiol. 2018, 55(7), 6076–6093. DOI: 10.1007/s12035-017-0798-6.
PubMed Web of Science ®Google Scholar
Dickey, C. A.; Kamal, A.; Lundgren, K.; Klosak, N.; Bailey, R. M.; Dunmore, J.; Ash, P.; Shoraka, S.; Zlatkovic, J.; Petrucelli, L. et al, The High-Affinity HSP90-CHIP Complex Recognizes and Selectively Degrades Phosphorylated Tau Client Proteins. J. Clin. Invest. 2007, 117(3), 648–658.
PubMed Web of Science ®Google Scholar
Ahmad, W.; Ijaz, B.; Shabbiri, K.; Ahmed, F.; Rehman, S. Oxidative Toxicity in Diabetes and Alzheimer’s Disease: Mechanisms Behind ROS/RNS Generation. J. Biomed. Sci. 2017, 24(1), 1–10. DOI: 10.1186/s12929-017-0379-z.
PubMedGoogle Scholar
Niedzielska, E.; Smaga, I.; Gawlik, M.; Moniczewski, A.; Stankowicz, P.; Pera, J.; Filip, M. Oxidative Stress in Neurodegenerative Diseases. Mol. Neurobiol. 2016, 53(6), 4094–4125. DOI: 10.1007/s12035-015-9337-5.
PubMed Web of Science ®Google Scholar
Berger, J.; Dorninger, F.; Forss-Petter, S.; Kunze, M. Peroxisomes in Brain Development and Function. Biochim. Biophys. Acta Mol. Cell Res. 2016, 1863(5), 934–955. DOI: 10.1016/j.bbamcr.2015.12.005.
PubMed Web of Science ®Google Scholar
Kou, J.; Kovacs, G. G.; Höftberger, R.; Kulik, W.; Brodde, A.; Forss-Petter, S.; Hönigschnabl, S.; Gleiss, A.; Brügger, B.; Wanders, R. Peroxisomal Alterations in Alzheimer’s Disease. Acta. Neuropathol 2011, 122(3), 271–283. DOI: 10.1007/s00401-011-0836-9.
PubMed Web of Science ®Google Scholar
Prosdocimi, T.; De Gioia, L.; Zampella, G.; Bertini, L. On the Generation of OH· Radical Species from H 2 O 2 by Cu (I) Amyloid Beta Peptide Model Complexes: A DFT Investigation. JBIC J. Biol. Inorg. Chem. 2016, 21, 197–212. DOI: 10.1007/s00775-015-1322-y.
PubMed Web of Science ®Google Scholar
Selkoe, D. J.; Hardy, J. The Amyloid Hypothesis of Alzheimer’s Disease at 25 Years. EMBO Mol. Med. 2016, 8, 595–608. DOI: 10.15252/emmm.201606210.
PubMed Web of Science ®Google Scholar
Huang, B.; Liu, J.; Fu, S.; Zhang, Y.; Li, Y.; He, D.; Ran, X.; Yan, X.; Du, J.; Meng, T. α-Cyperone Attenuates H2O2-Induced Oxidative Stress and Apoptosis in SH-SY5Y Cells via Activation of Nrf2. Front. Pharmacol. 2020, 11, 281. DOI: 10.3389/fphar.2020.00281.
PubMed Web of Science ®Google Scholar
Othman, S. B.; Yabe, T. Use of Hydrogen Peroxide and Peroxyl Radicals to Induce Oxidative Stress in Neuronal Cells. RAS. 2015, 3, 40–45. DOI: 10.7831/ras.3.40.
Google Scholar
Park, H. R.; Lee, H.; Park, H.; Jeon, J. W.; Cho, W.-K.; Ma, J. Y. Neuroprotective Effects of Liriope Platyphylla Extract Against Hydrogen Peroxide-Induced Cytotoxicity in Human Neuroblastoma SH-SY5Y Cells. BMC Complement. Altern. Med. 2015, 15(1), 1–11. DOI: 10.1186/s12906-015-0679-3.
PubMedGoogle Scholar
Wang, J.; Liu, H.; Zhang, X.; Li, X.; Geng, L.; Zhang, H.; Zhang, Q. Sulfated Hetero-Polysaccharides Protect SH-SY5Y Cells from H2O2-Induced Apoptosis by Affecting the PI3K/Akt Signaling Pathway. Mar. Drugs. 2017b, 15(4), 110. DOI: 10.3390/md15040110.
PubMed Web of Science ®Google Scholar
Yao, D.; Wang, J.; Wang, G.; Jiang, Y.; Shang, L.; Zhao, Y.; Huang, J.; Yang, S.; Wang, J.; Yu, Y. Design, Synthesis and Biological Evaluation of Coumarin Derivatives as Novel Acetylcholinesterase Inhibitors That Attenuate H2O2-Induced Apoptosis in SH-SY5Y Cells. Bioorg. Chem. 2016, 68, 112–123. DOI: 10.1016/j.bioorg.2016.07.013.
PubMed Web of Science ®Google Scholar
Juan-García, A.; Caprioli, G.; Sagratini, G.; Mañes, J.; Juan, C. Coffee Silverskin and Spent Coffee Suitable as Neuroprotectors Against Cell Death by Beauvericin and α-Zearalenol: Evaluating Strategies of Treatment. Toxins (Basel). 2021, 13(2), 132. DOI: 10.3390/toxins13020132.
PubMed Web of Science ®Google Scholar
Kovalevich, J.; Langford, D. Considerations for the Use of SH-SY5Y Neuroblastoma Cells in Neurobiology. Neuronal Cell Cult. Methods Protoc. 2013, 1078, 9–21.
Google Scholar
Shipley, M. M.; Mangold, C. A.; Szpara, M. L. Differentiation of the SH-SY5Y Human Neuroblastoma Cell Line. JoVE (J. Vis. Exp.). 2016, 108(108), e53193. DOI: 10.3791/53193.
Google Scholar
Angeloni, S.; Freschi, M.; Marrazzo, P.; Hrelia, S.; Beghelli, D.; Juan-García, A.; Juan, C.; Caprioli, G.; Sagratini, G.; Angeloni, C.; et al. Antioxidant and Anti-Inflammatory Profiles of Spent Coffee Ground Extracts for the Treatment of Neurodegeneration. Oxid. Med. Cell Longev. 2021, 2021, 1–19. DOI: 10.1155/2021/6620913.
Web of Science ®Google Scholar
Amato, A.; Terzo, S.; Mulè, F. Natural Compounds as Beneficial Antioxidant Agents in Neurodegenerative Disorders: A Focus on Alzheimer’s Disease. Antioxidants. 2019, 8(12), 608. DOI: 10.3390/antiox8120608.
Web of Science ®Google Scholar
Naveed, M.; Hejazi, V.; Abbas, M.; Kamboh, A. A.; Khan, G. J.; Shumzaid, M.; Ahmad, F.; Babazadeh, D.; FangFang, X.; Modarresi-Ghazani, F. Chlorogenic Acid (CGA): A Pharmacological Review and Call for Further Research. Biomed. Pharmacother. 2018, 97, 67–74. DOI: 10.1016/j.biopha.2017.10.064.
PubMed Web of Science ®Google Scholar
Oboh, G.; Agunloye, O. M.; Akinyemi, A. J.; Ademiluyi, A. O.; Adefegha, S. A. Comparative Study on the Inhibitory Effect of Caffeic and Chlorogenic Acids on Key Enzymes Linked to Alzheimer’s Disease and Some Pro-Oxidant Induced Oxidative Stress in rats’ Brain-In Vitro. Neurochem. Res. 2013b, 38(2), 413–419. DOI: 10.1007/s11064-012-0935-6.
PubMed Web of Science ®Google Scholar
Gao, L.; Li, X.; Meng, S.; Ma, T.; Wan, L.; Xu, S. chlorogenic Acid Alleviates Aβ25-35-Induced Autophagy and Cognitive Impairment via the mTOR/TFEB Signaling Pathway. Drug Des. Devel. Ther. 2020, Volume 14, 1705–1716. DOI: 10.2147/DDDT.S235969.
Web of Science ®Google Scholar
Kim, S.; Park, R.; Jeon, H.; Kwon, Y.; Chun, W. Neuroprotective Effects of 3, 5‐Dicaffeoylquinic Acid on Hydrogen Peroxide‐Induced Cell Death in SH‐SY5Y Cells. Phytother. Res. 2005, 19, 243–245. DOI: 10.1002/ptr.1652.
PubMed Web of Science ®Google Scholar
Izuta, H.; Shimazawa, M.; Tazawa, S.; Araki, Y.; Mishima, S.; Hara, H. Protective Effects of Chinese Propolis and Its Component, Chrysin, Against Neuronal Cell Death via Inhibition of Mitochondrial Apoptosis Pathway in SH-SY5Y Cells. J. Agric. Food. Chem. 2008, 56(19), 8944–8953. DOI: 10.1021/jf8014206.
PubMed Web of Science ®Google Scholar
Arya, A.; Chahal, R.; Rao, R.; Rahman, M. H.; Kaushik, D.; Akhtar, M. F.; Saleem, A.; Khalifa, S. M. A.; El-Seedi, H. R.; Kamel, M. Acetylcholinesterase Inhibitory Potential of Various Sesquiterpene Analogues for Alzheimer’s Disease Therapy. Biomolecules. 2021, 11, 350. DOI: 10.3390/biom11030350.
PubMed Web of Science ®Google Scholar
Cheng, K.-C.; Chiang, H.-C. XBP1 and PERK Have Distinct Roles in Aβ-Induced Pathology. Mol. Neurobiol. 2018, 55(9), 7523–7532. DOI: 10.1007/s12035-018-0942-y.
PubMed Web of Science ®Google Scholar
Miyamae, Y.; Han, J.; Sasaki, K.; Terakawa, M.; Isoda, H.; Shigemori, H. 3, 4, 5-Tri-O-Caffeoylquinic Acid Inhibits Amyloid β-Mediated Cellular Toxicity on SH-SY5Y Cells Through the Upregulation of PGAM1 and G3PDH. Cytotechnology. 2011, 63(2), 191–200. DOI: 10.1007/s10616-011-9341-1.
PubMed Web of Science ®Google Scholar
Ma, E.-H.; Rathnayake, A. U.; Lee, J. K.; Lee, S.-M.; Byun, H.-G. Characterization of β-Secretase Inhibitory Extracts from Sea Cucumber (Stichopus Japonicus) Hydrolysis with Their Cellular Level Mechanism in SH-SY5Y Cells. Eur. Food Res. Technol. 2021, 247(8), 2039–2052. DOI: 10.1007/s00217-021-03770-6.
Web of Science ®Google Scholar
Rathnayake, A. U.; Abuine, R.; Palanisamy, S.; Lee, J. K.; Byun, H.-G. Characterization and Purification of β− Secretase Inhibitory Peptides Fraction from Sea Cucumber (Holothuria Spinifera) Enzymatic Hydrolysates. Process Biochem. 2021, 111, 86–96. DOI: 10.1016/j.procbio.2021.10.007.
Web of Science ®Google Scholar
Wang, L.; Yin, Y.-L.; Liu, X.-Z.; Shen, P.; Zheng, Y.-G.; Lan, X.-R.; Lu, C.-B.; Wang, J.-Z. Current Understanding of Metal Ions in the Pathogenesis of Alzheimer’s Disease. Transl. Neurodegener. 2020, 9(1), 1–13. DOI: 10.1186/s40035-020-00189-z.
PubMed Web of Science ®Google Scholar
Williams, R. J.; Spencer, J. P. E. Flavonoids, Cognition, and Dementia: Actions, Mechanisms, and Potential Therapeutic Utility for Alzheimer Disease. Free Radic. Biol. Med. 2012, 52, 35–45. DOI: 10.1016/j.freeradbiomed.2011.09.010.
PubMed Web of Science ®Google Scholar
Agostinho, P.; Cunha, R. A.; Oliveira, C. Neuroinflammation, Oxidative Stress and the Pathogenesis of Alzheimer’s Disease. Curr. Pharm. Des. 2010, 16(25), 2766–2778. DOI: 10.2174/138161210793176572.
PubMed Web of Science ®Google Scholar
Ceulemans, A.-G.; Zgavc, T.; Kooijman, R.; Hachimi-Idrissi, S.; Sarre, S.; Michotte, Y. The Dual Role of the Neuroinflammatory Response After Ischemic Stroke: Modulatory Effects of Hypothermia. J. Neuroinflammation. 2010, 7(1), 1–18. DOI: 10.1186/1742-2094-7-74.
PubMedGoogle Scholar
MacEwan, D. J. TNF Receptor Subtype Signalling: Differences and Cellular Consequences. Cell. Signal. 2002, 14(6), 477–492. DOI: 10.1016/S0898-6568(01)00262-5.
PubMed Web of Science ®Google Scholar
Taylor, D. L.; Jones, F.; Kubota, E. S. F. C. S.; Pocock, J. M. Stimulation of Microglial Metabotropic Glutamate Receptor mGlu2 Triggers Tumor Necrosis Factor α-Induced Neurotoxicity in Concert with Microglial-Derived Fas Ligand. J. Neurosci. 2005, 25, 2952–2964. DOI: 10.1523/JNEUROSCI.4456-04.2005.
PubMed Web of Science ®Google Scholar
Walker, D.; Lue, L.-F. Anti-Inflammatory and Immune Therapy for Alzheimer’s Disease: Current Status and Future Directions. Curr. Neuropharmacol. 2007, 5, 232–243. DOI: 10.2174/157015907782793667.
PubMed Web of Science ®Google Scholar
Semwal, P.; Painuli, S.; Abu-Izneid, T.; Rauf, A.; Sharma, A.; Daştan, S. D.; Kumar, M.; Alshehri, M. M.; Taheri, Y.; Das, R. Diosgenin: An Updated Pharmacological Review and Therapeutic Perspectives. Oxid. Med. Cell Longev. 2022, 2022, 1–17. DOI: 10.1155/2022/1035441.
Web of Science ®Google Scholar
Sharifi-Rad, J.; Herrera-Bravo, J.; Semwal, P.; Painuli, S.; Badoni, H.; Ezzat, S. M.; Farid, M. M.; Merghany, R. M.; Aborehab, N. M.; Salem, M. A. Artemisia Spp.: An Update on Its Chemical Composition, Pharmacological and Toxicological Profiles. Oxid. Med. Cell Longev. 2022b, 2022, 1–23. DOI: 10.1155/2022/5628601.
Web of Science ®Google Scholar
Javed, Z.; Khan, K.; Herrera-Bravo, J.; Naeem, S.; Iqbal, M. J.; Raza, Q.; Sadia, H.; Raza, S.; Bhinder, M.; Calina, D. Myricetin: Targeting Signaling Networks in Cancer and Its Implication in Chemotherapy. Cancer Cell Int. 2022, 22(1), 239. DOI: 10.1186/s12935-022-02663-2.
PubMed Web of Science ®Google Scholar
Mangialasche, F.; Solomon, A.; Winblad, B.; Mecocci, P.; Kivipelto, M. Alzheimer’s Disease: Clinical Trials and Drug Development. Lancet. Neurol. 2010, 9, 702–716. DOI: 10.1016/S1474-4422(10)70119-8.
PubMed Web of Science ®Google Scholar
Ahmad, I.; Aqil, F.; Owais, M. Modern Phytomedicine: Turning Medicinal Plants into Drugs; John Wiley & Sons, 2006. DOI:10.1002/9783527609987.
Google Scholar
Salehi, B.; Sharifi-Rad, J.; Cappellini, F.; Reiner, Ž.; Zorzan, D.; Imran, M.; Sener, B.; Kilic, M.; El-Shazly, M.; Fahmy, N. M. The Therapeutic Potential of Anthocyanins: Current Approaches Based on Their Molecular Mechanism of Action. Front. Pharmacol. 2020, 11, 1300. DOI: 10.3389/fphar.2020.01300.
PubMed Web of Science ®Google Scholar
Leyva-Gomez, G.; Cortes, H.; Magana, J. J.; Leyva-García, N.; Quintanar-Guerrero, D.; Florán, B. Nanoparticle Technology for Treatment of Parkinson’s Disease: The Role of Surface Phenomena in Reaching the Brain. Drug Discov. Today. 2015, 20(7), 824–837. DOI: 10.1016/j.drudis.2015.02.009.
PubMed Web of Science ®Google Scholar
Quispe, C.; Herrera-Bravo, J.; Khan, K.; Javed, Z.; Semwal, P.; Painuli, S.; Kamiloglu, S.; Martorell, M.; Calina, D.; Sharifi-Rad, J. Therapeutic Applications of Curcumin Nanomedicine Formulations in Cystic Fibrosis. Prog. Biomater. 2022, 11(4), 321–329. DOI: 10.1007/s40204-022-00198-3.
PubMed Web of Science ®Google Scholar
Docea, A. O.; Calina, D.; Buga, A. M.; Zlatian, O.; Paoliello, M. M. B.; Mogosanu, G. D.; Streba, C. T.; Popescu, E. L.; Stoica, A. E.; Bîrcă, A. C. The Effect of Silver Nanoparticles on Antioxidant/pro-Oxidant Balance in a Murine Model. Int. J. Mol. Sci. 2020, 21, 1233. DOI: 10.3390/ijms21041233.
PubMed Web of Science ®Google Scholar
Sharifi-Rad, J.; Bahukhandi, A.; Dhyani, P.; Sati, P.; Capanoglu, E.; Docea, A. O.; Al-Harrasi, A.; Dey, A.; Calina, D. Therapeutic Potential of Neoechinulins and Their Derivatives: An Overview of the Molecular Mechanisms Behind Pharmacological Activities. Front. Nutr. 2021a, 8, 664197. DOI: 10.3389/fnut.2021.664197.
PubMed Web of Science ®Google Scholar
Sharifi-Rad, J.; Dey, A.; Koirala, N.; Shaheen, S.; El Omari, N.; Salehi, B.; Goloshvili, T.; Cirone Silva, N. C.; Bouyahya, A.; Vitalini, S. Cinnamomum Species: Bridging Phytochemistry Knowledge, Pharmacological Properties and Toxicological Safety for Health Benefits. Front. Pharmacol. 2021b, 12, 600139. DOI: 10.3389/fphar.2021.600139.
PubMed Web of Science ®Google Scholar
Sharifi-Rad, J.; Quispe, C.; Imran, M.; Rauf, A.; Nadeem, M.; Gondal, T. A.; Ahmad, B.; Atif, M.; Mubarak, M. S.; Sytar, O. Genistein: An Integrative Overview of Its Mode of Action, Pharmacological Properties, and Health Benefits. Oxid. Med. Cell Longev. 2021c, 2021, 1–36. DOI: 10.1155/2021/3268136.
Web of Science ®Google Scholar
Ramalho, M. J.; Andrade, S.; Loureiro, J. A.; Carmo Pereira, M. D. Nanotechnology to Improve the Alzheimer’s Disease Therapy with Natural Compounds. Drug Deliv. Transl. Res. 2020, 10, 380–402. DOI: 10.1007/s13346-019-00694-3.
PubMed Web of Science ®Google Scholar
Del Prado-Audelo, M. L.; Caballero-Florán, I. H.; Meza-Toledo, J. A.; Mendoza-Muñoz, N.; González-Torres, M.; Florán, B.; Cortés, H.; Leyva-Gómez, G. Formulations of Curcumin Nanoparticles for Brain Diseases. Biomolecules. 2019, 9, 56. DOI: 10.3390/biom9020056.
PubMed Web of Science ®Google Scholar
Naqvi, S.; Panghal, A.; Flora, S. J. S. Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs. Front. Neurosci. 2020, 14, 494. DOI: 10.3389/fnins.2020.00494.
PubMed Web of Science ®Google Scholar
Kamatou, G. P. P.; Viljoen, A. M. A Review of the Application and Pharmacological Properties of α-Bisabolol and α-Bisabolol-Rich Oils. J. Am. Oil Chem. Soc. 2010, 87(1), 1–7. DOI: 10.1007/s11746-009-1483-3.
Web of Science ®Google Scholar
Anand, P.; Kunnumakkara, A. B.; Newman, R. A.; Aggarwal, B. B. Bioavailability of Curcumin: Problems and Promises. Mol. Pharm. 2007, 4(6), 807–818. DOI: 10.1021/mp700113r.
PubMed Web of Science ®Google Scholar
Islam, M. T.; Ali, E. S.; Uddin, S. J.; Shaw, S.; Islam, M. A.; Ahmed, M. I.; Shill, M. C.; Karmakar, U. K.; Yarla, N. S.; Khan, I. N. Phytol: A Review of Biomedical Activities. Food Chem. Toxicol. 2018, 121, 82–94. DOI: 10.1016/j.fct.2018.08.032.
PubMed Web of Science ®Google Scholar
Mohar, D. S.; Malik, S. The Sirtuin System: The Holy Grail of Resveratrol? J. Clin. Exp. Cardiolog. 2012, 3. DOI: 10.4172/2155-9880.1000216.
PubMedGoogle Scholar
Walle, T. Bioavailability of Resveratrol. Ann. N Y Acad. Sci. 2011, 1215(1), 9–15. DOI: 10.1111/j.1749-6632.2010.05842.x.
PubMed Web of Science ®Google Scholar
Bacci, A.; Runfola, M.; Sestito, S.; Rapposelli, S. Beyond Antioxidant Effects: Nature-Based Templates Unveil New Strategies for Neurodegenerative Diseases. Antioxidants. 2021, 10(3), 367. DOI: 10.3390/antiox10030367.
Web of Science ®Google Scholar
Calina, D.; Hartung, T.; Docea, A. O.; Spandidos, D. A.; Egorov, A. M.; Shtilman, M. I.; Carvalho, F.; Tsatsakis, A. COVID-19 Vaccines: Ethical Framework Concerning Human Challenge Studies. DARU J. Pharm. Sci. 2020c, 28(2), 807–812. DOI: 10.1007/s40199-020-00371-8.
Web of Science ®Google Scholar
Calina, D.; Sarkar, C.; Arsene, A. L.; Salehi, B.; Docea, A. O.; Mondal, M.; Islam, M. T.; Zali, A.; Sharifi-Rad, J. Recent Advances, Approaches and Challenges in Targeting Pathways for Potential COVID-19 Vaccines Development. Immunol. Res. 2020d, 68(6), 315–324. DOI: 10.1007/s12026-020-09154-4.
PubMed Web of Science ®Google Scholar
Torequl Islam, M.; Nasiruddin, M.; Khan, I. N.; Mishra, S. K.; Kudrat-E-Zahan, M.; Alam Riaz, T.; Ali, E. S.; Rahman, M. S.; Mubarak, M. S.; Martorell, M. A Perspective on Emerging Therapeutic Interventions for COVID-19. Front. Public Health. 2020, 8, 281. DOI: 10.3389/fpubh.2020.00281.
PubMed Web of Science ®Google Scholar
Calina, D.; Hernández, A. F.; Hartung, T.; Egorov, A. M.; Izotov, B. N.; Nikolouzakis, T. K.; Tsatsakis, A.; Vlachoyiannopoulos, P. G.; Docea, A. O. Challenges and Scientific Prospects of the Newest Generation of mRNA-Based Vaccines Against SARS-CoV-2. Life. 2021, 11, 907. DOI: 10.3390/life11090907.
PubMedGoogle Scholar
Kostoff, R. N.; Kanduc, D.; Porter, A. L.; Shoenfeld, Y.; Calina, D.; Briggs, M. B.; Spandidos, D. A.; Tsatsakis, A. Vaccine-And Natural Infection-Induced Mechanisms That Could Modulate Vaccine Safety. Toxicol. Rep. 2020, 7, 1448–1458. DOI: 10.1016/j.toxrep.2020.10.016.
PubMed Web of Science ®Google Scholar
Neagu, M.; Calina, D.; Docea, A. O.; Constantin, C.; Filippini, T.; Vinceti, M.; Drakoulis, N.; Poulas, K.; Nikolouzakis, T. K.; Spandidos, D. A. Back to Basics in COVID‐19: Antigens and Antibodies—Completing the Puzzle. J. Cell Mol. Med. 2021, 25(10), 4523–4533. DOI: 10.1111/jcmm.16462.
PubMed Web of Science ®Google Scholar
Albertini, C.; Salerno, A.; de Sena Murteira Pinheiro, P.; Bolognesi, M. L. From Combinations to Multitarget‐Directed Ligands: A Continuum in Alzheimer’s Disease Polypharmacology. Med. Res. Rev. 2021, 41(5), 2606–2633. DOI: 10.1002/med.21699.
PubMed Web of Science ®Google Scholar

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Advances in Alzheimer’s disease therapeutics: biochemistry, exploring bioactive compounds and novel approaches

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Advances in Alzheimer’s disease therapeutics: biochemistry, exploring bioactive compounds and novel approaches

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date